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ABSTRACT 
 
 
The ability to walk can be severely compromised by a lower-limb amputation, which can 
have long-reaching consequences to the individual’s health and safety. It has been 
reported that the high incidence of lower back pain and joint degradation experienced by 
lower-limb amputees can be attributed to the way amputees carry themselves during 
walking. The techniques adopted by amputees have a direct correlation to the muscle 
strength of the residual limb. It was theorized in this study that a hip strength training 
program would improve amputees’ gait performance. An additional aim of the study was 
to determine if the training program was sufficient to enable lower-limb amputees to run. 
To assess potential changes in walking gait biomechanics as a consequence of the hip 
strengthening training, kinematic movement data collected with computerized motion 
capture techniques were analyzed using both novel and traditional gait analysis methods.  
A novel technique of time warping gait data to kinematic gait events was developed and 
validated initially using data from healthy adult males with a simulated knee injury. This 
technique provided additional insights into temporal shifts in gait behaviors under the 
simulated injury, as well as providing greater alignment of the kinematic curves. This 
tool along with standard spatiotemporal metrics and kinematic profile analysis were used 
to analyze the results from the hip strengthening study. Another analysis of the hip 
strengthening program data found that the metabolic cost of walking in the training group 
decreased, hip flexor and extensor strength increased, and all but one member of the 
training group were able to run after training. In the current study, however, no 
significant changes in the kinematic gait behaviors for the training group in the pre- vs. 
post- training analysis were found. The control group’s kinematic profiles did show some 
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significant changes after the ten-week period, indicative of deterioration in gait 
performance. These results suggest that the hip strengthening program may have 
prevented similar trends from occurring in the training group. The gait analysis tools 
employed on this data set provided greater insight into the kinematic strategies employed 
by lower-limb amputees, as well as emphasizing the necessity for continuous muscle 
strength training in this population. 
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CHAPTER 1: INTRODUCTION 
 
 
Locomotion is a fundamental element of everyday life. Gait can be defined as a cyclic 
event, which simultaneously propels the body forward and maintains stance stability. As 
an individual advances, one limb provides a base of support, while the other limb is 
shifted forward to create a new base [1]. This ability can be severely impacted by a 
lower-limb amputation, stroke, or other physical impairment causing weakness or loss of 
function, and can have long-reaching consequences to the individual’s health and safety. 
 
In the United States alone, there are an estimated 159,000 people per year who undergo a 
lower-limb amputation [2]. There are currently 1.6 million people living in the United 
States with the loss of a lower limb, and this number is expected to double by the year 
2050 [3]. There are many forms of lower-limb amputations (e.g. knee, ankle 
disarticulation, partial foot amputation), but the two major forms this thesis addresses are 
unilateral (one sided) transtibial (TT, below-knee) and transfemoral (TF, above-knee) 
amputations.  It has been well-documented that individuals with lower-limb amputations 
have a higher incidence of lower-back and hip and/or knee joint pain, and it has been 
hypothesized that this pain can be attributed to the way amputees carry themselves during 
walking [4, 5]. The techniques adopted by amputees can be linked to their residual limb’s 
muscle strength, and it has been shown that muscle strength in the residual limb 
decreases over time [6]. In order to prevent muscle atrophy in amputees, it is 
recommended to implement training programs focused on strengthening the muscles of 
the residual limb [7]. By understanding the mechanisms behind lower-limb amputee gait, 
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it may be possible to develop a training protocol that will not only strengthen the muscles 
of the thigh, but also to reduce the metabolic cost associated with amputee gait.  
 
1.1. UNDERSTANDING GAIT 
 
Gait can be broken down into a repetitive series of patterns, each representing distinct 
functional tasks. There are eight of these sub-phases of gait: 1) initial contact, 2) loading 
response, 3) mid stance, 4) terminal stance, 5) pre-swing, 6) initial swing, 7) mid-swing, 
and 8) terminal swing [1]. Sub-phases (1) and (2) are involved in weight acceptance, 
which involves shock absorption, initial limb stability, and the preservation of 
progression.  Sub-phases (3) and (4) make up the single limb support section of gait. 
During single-limb support, one limb entirely supports the weight of the body in both the 
sagittal (side) and coronal (frontal) planes. Limb advancement contains sub-phases (5)-
(8), and involves the preparatory posturing of the support limb, as well as movement of 
the limb itself. Knowing the functional requirements of normal gait allows for greater 
insight into the changes incurred by pathological or injured gait. 
 
Analyzing human gait can be done in a variety of ways, but one of the most common 
methods is through analyzing temporal and spatial gait parameters, which can provide 
timing and position information about an individual’s gait patterns. A stride consists of 
one heel strike to the consecutive heel strike by the same foot, while a step is recognized 
as being the interval between sequential heel strikes by the ipsilateral and contralateral 
feet (Fig 1.1). 
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Figure 1.1: Definition of Spatial and Temporal Characteristics of Gait 
 
 
Two steps make up each gait cycle, or each stride, and each side is roughly symmetrical 
in healthy, able-bodied individuals.  Step width is a measure of the medial-lateral 
distance between feet at heel strikes, and cadence is defined as the number of steps taken 
per unit of time. While these parameters remain relatively symmetrical between limbs in 
able-bodied individuals, amputees very often adapt a unique way of walking which 
differs from able-bodied persons [8]. 
 
1.2. CHARACTERISTICS OF AMPUTEE GAIT 
 
1.2.1. Transtibial Amputee Gait 
There have been many studies which have been aimed at quantifying the differences 
between transtibial amputee gait and able-bodied gait. In general, transtibial amputees 
have been shown to have decreased cadence, stride length, and a slower comfortable 
walking speed as compared to able-bodied individuals [8-10]. Transtibial amputees also 
generally take longer to initiate gait and reach a steady-state walking speed than able-
bodied individuals [11]. It has also been shown that transtibial amputees have wider step 
widths and shorter step lengths, which indicates decreased stability and less perceived 
security than able-bodied subjects [10]. However, amputee gait also differs from able-
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bodied gait in that transtibial gait has asymmetry present between the prosthetic and 
sound limbs. It has been shown that step time, swing time, and step length were longer 
while stride length and stance time were shorter on the prosthetic limb as compared to the 
intact limb [8, 9]. Knee flexion in the prosthetic limb has also been reported as 
significantly higher than the intact limb at heel strike, which can be linked to the ideal 
positioning of the prosthetic socket [9]. In general, the sound limb of transtibial amputees 
carries more weight than the amputated limb, and a strong relationship was found 
between the weight-bearing on the amputated limb and the strength of the residual 
muscles [12]. The relationship is such that the greater the strength of the residual limb, 
the greater the weight bearing capacity. 
 
The leg muscles of transtibial amputees also behave differently than able-bodied 
individuals. In able-bodied individuals, the primary forward momentum required for 
walking is provided by the ankle plantarflexors [13]. In transtibial amputees, the 
plantarflexors are missing, so it has been proposed that this forward propulsion is 
provided by hyperactivity of the hip extensors [7, 9, 10].  This increased muscle activity 
in the hip extensors is achieved by the hamstrings, which in turn generates an above-
normal knee flexor moment, which must be cancelled out by co-contracting in the 
quadriceps [7, 9, 14]. This co-contraction causes the net knee moment during stance to be 
near zero. During push-off, the hamstrings become less active, but the knee extensors 
remain active well into swing.  These changes in muscle activation give an indication of 
how differently transtibial amputees walk as compared to able-bodied individuals, and it 
is apparent how vital the hip extensor muscles are to forward propulsion in this 
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population. Therefore, a strength training program targeting these muscles could 
potentially improve not only the weight-bearing capacity of the residual limb, but it may 
also improve the overall walking characteristics of transtibial amputees. 
 
1.2.2. Transfemoral Amputee Gait 
The differences between transfemoral amputee gait and able-bodied individuals are 
similar to those between transtibial amputees and able-bodied, but the differences have 
been magnified in the transfemoral amputees. In terms of time-distance parameters, 
transfemoral amputees, as compared to both transtibial and able-bodied individuals, have 
a slower gait speed, decreased cadence, increased cycle time, decreased stride length, and 
a decreased stance phase on the prosthetic side [15-17]. Transfemoral amputees also 
show decreased hip flexion and extension, as well as increased hip abduction and 
adduction, and decreased knee flexion and extension on the intact side. In a difference 
from transtibial amputees, transfemoral amputees display a much larger range of motion 
of the pelvis and trunk. The angular range of motion of the pelvis in transfemoral 
amputees was significantly higher in the sagittal and frontal planes than that of able-
bodied individuals, while the range of motion of the trunk was significantly higher in all 
three planes in the transfemoral amputees [15, 16]. The additional trunk movement 
significantly changes the upper body angular accelerations, which may in turn alter the 
individual’s global torque production, which has a profound effect on joint loading [16].  
Asymmetrical joint loading of the knee and hips has been shown to have serious 
consequences in amputees, and will be discussed further.  
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The additional movement of the pelvis, which causes asymmetrical joint loading, can be 
classified in the following ways: (1) rotation around the transverse plane, or pelvic tilt, 
and (2) rotation around the sagittal plane, or hip-hiking. Hip hiking can be explained as 
either a compensatory technique to clear the prosthetic limb during swing, or as a 
weakness in the hip abductors. Weakness in the hip abductors can also be responsible for 
the increase in pelvic tilt, as these muscles are responsible for stabilizing the pelvis 
during locomotion [16]. There are also significant differences in the hamstrings, 
quadriceps, and tibialis anterior muscles of the sound limb of transfemoral amputees 
when compared to able-bodied individuals. The activation of the quadriceps and 
hamstring muscles of the intact limb were significantly lower than that of able-bodied 
individuals, while the tibialis anterior and gastrocnemius activations were significantly 
higher [15]. The higher activation in these muscles were attributed to the excessive power 
requirements of the sound ankle to compensate for the prosthetic limb. As in the 
transtibial amputees, there was also a high degree of co-activity in the hamstring muscles. 
While these insights are useful in evaluating transfemoral gait, there are several 
characteristics shared between transtibial and transfemoral amputees which indicate the 
necessity of creating a muscle strengthening protocol. 
 
1.2.3. General Amputee Gait 
There are many explanations for the differences observed between transfemoral and 
transtibial amputees. The quality of amputee gait can depend on many factors, including 
a pain-free stump, an optimally fitted socket, acceptable alignment of the prosthesis, the 
type of prosthetic knee or foot, and the overall health and physical condition of the 
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amputee [7-9, 14, 18]. However, it has also been observed that the level of the 
amputation (i.e. the length of the residual limb) is one of the more significant contributors 
to the asymmetry to amputee gait [16, 19]. These studies have shown that the longer the 
residual limb, the more control the individual has over the prosthesis, the less movement 
of the trunk and pelvis, and thus the less metabolically costly.  
 
As mentioned, movement of the pelvis can be explained by the relative strength of hip 
muscles, and it has been shown that the amount of atrophy in the hip abductors depends 
on the level of amputation; the higher the amputation level, the more muscle atrophy 
occurs [15, 17]. Thus, the relative strength of the thigh muscles directly contributes to the 
metabolic cost of walking in amputees [18, 20]. It has been very well-documented that 
lower-limb amputees display progressive decreases in muscle strength over time, and 
increases in muscle atrophy [6, 21-25]. This decrease in muscle strength can lead to 
changes in kinematic performance, i.e. walking ability decreases over time, but it can also 
have a significant impact on the joints of the hips and intact knee.  Studies have shown 
that strength asymmetry is correlated with an increase in osteoarthritis risk in the hips, 
and that the incidence of osteoarthritis is greater in the intact limb than the amputated 
limb [4, 5, 26, 27]. These same studies also show an increase in osteoporosis in the 
residual limb hip, which may be a form of disuse atrophy. It is hypothesized that the 
reason for the increase in osteoarthritis in the intact limb is due to the unequal impact 
loading adopted by amputees during gait, and that this loading can be changed by a 
variety of factors, even walking speed [28, 29]. Therefore, in an attempt to reduce the 
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asymmetrical loading between the limbs, and thus reduce pain caused by osteoarthritis, it 
is necessary to improve muscle strength in the thighs and hips of amputees. 
 
 
1.3. METHODS FOR IMPROVING HIP STRENGTH 
 
Hip strengthening programs are commonly used to improve gait in other populations 
aside from amputees. A study done on children with Cerebral Palsy showed that strength 
training of the hip and knee extensors could potentially improve walking function and 
alignment in patients with whom weakness was the major contributor to gait deficiencies 
[30]. The effect of strengthening the hip and knee flexors has also been assessed in 
patients with hemiparesis, or unilateral muscle weakness of the body [31, 32]. These 
studies have shown that as the strength of the affected plantarflexors and hip flexors 
increased, the participants’ walking speeds increased, and their maximal levels of effort 
decreased, when compared to the pre-training data. 
 
Hip strengthening programs have also been used with success in amputees. A study done 
with transtibial amputees used isometric strength training to improve muscle volume and 
strength, with the result of better prosthesis retention during walking, and a decrease in 
time spent in swing on the prosthetic limb [33].    A different study used isokinetic 
strength training in transtibial amputees, with the result of improved muscle strength and 
patient-reported improvements in gait [22].  One final study combined psychological and 
physiotherapeutic treatment to improve gait in transfemoral amputees.  This particular 
study was aimed at integrating the prosthesis into normal movements and increasing 
body-awareness.  This study ultimately showed that the subjects’ comfortable walking 
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speed increased, there was more symmetry at the hip joint, more muscle work was done 
on the amputated side, and the lower back pain experienced by the amputees disappeared 
[10, 34].   
 
This thesis will attempt to evaluate the efficacy of the hip strengthening training program 
developed by Dr. Lee Nolan at Karolinska Institutet, in Sweden [35]. It does so by 
evaluating the kinematics of seven lower-limb amputees (four TT, three TF) who 
participated in a ten-week training protocol, as compared to eight amputees (three TT, 
five TF) in a control group, who continued their normal habits. 
 
 
1.4. METHODS FOR TIME NORMALIZING GAIT DATA 
 
Locomotion is typically assumed to be periodic, so for analysis purposes, data are 
frequently broken into gait cycles. However, the duration and timing of gait cycle events 
can vary, even under the steadiest of conditions [36, 37]. Therefore, in order to assess 
average behavior over several gait cycles or from different populations, it is first 
necessary to temporally align the data. There are several techniques employed on time-
series data, with different methods preferred depending on the application. A description 
of the most frequently used techniques to normalize biomechanical data follows. 
 
1.4.1. Linear Length Normalization 
 
The most common technique for temporally aligning gait data is by expressing the data in 
percentages, from 0 to 100%, of the gait cycle. This approach linearly expands or 
compresses the time axis of each gait cycle, such that all gait cycles have the same length. 
While this technique removes the temporal differences caused by changes in the length of 
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a gait cycle, temporal differences between gait events (e.g. heel strikes, toe-offs), may 
still exist. Thus, movement patterns averaged over multiple gait cycles may express 
reduced peak magnitudes and increased standard deviations due to inter- and intra-cycle 
variability in timing [37, 38].  
 
1.4.2. Dynamic Time Warping 
 
Dynamic time warping is a technique used in aligning various types of biometric data [39, 
40], and non-linearly compresses the time-axis data of a trajectory. Dynamic time 
warping aligns a test trajectory to a target trajectory by minimizing the difference in 
intensity between the two curves. This technique can also be applied in a piecewise 
manner, once the data has been broken into distinct subphases of gait. While dynamic 
time warping produces successful alignment when the two curves differ in timing but not 
intensity, the technique produces poor temporal alignment when the subphases of gait 
exhibit systematic intensity differences between the test and target curves [41]. One other 
potential drawback to this technique is the reliance of the constraints placed on the 
system by the user. If the constraints are too lenient, the data may be distorted, but 
alignment may not be achieved if the constraints are too harsh.  
 
1.4.3. Derivative Dynamic Time Warping 
 
Derivative dynamic time warping is a technique developed to address the limitations of 
the minimization criteria present in dynamic time warping. This technique also non-
linearly compresses or expands the time axis of a test trajectory to a target trajectory, but 
it determines the temporal alignment which minimizes the difference between the 
estimated local derivatives of both trajectories. With this technique, the temporal 
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alignment is successful unless the shape of the two curves is drastically different. As with 
dynamic time warping, the final alignment between the two curves is highly dependent 
on user constraints. 
 
1.4.4. Piecewise Linear Length Normalization 
 
Piecewise linear length normalization is a curve registration technique which expands or 
compresses the time axis of the target curve in a linear manner between specified points 
of interest along the gait cycle [38]. The points of interest can be any characterizing 
points within the gait cycle, as long as it is possible to identify these features in all 
subjects and experimental conditions. Examples of these could be peaks, valleys, or gait 
events. This technique also allows for greater insight into temporal and intensity 
differences between gait cycle data throughout the entire cycle.  
 
Therefore, based on the advantages and disadvantages of the described alignment 
techniques, PLLN was chosen to analyze the amputee data set. This technique will not 
only align the data, but it can also provide added insight into the movement patterns 
adopted by amputees, and how this changes as a result of a training program. 
 
1.5. AN INTRODUCTION TO OPENSIM 
 
In order to create the kinematic curves to be analyzed, an open-source software called 
OpenSim was used to evaluate the experimental motion capture data from the amputee 
data set. OpenSim is a platform for modeling, simulating, and analyzing the 
neuromusculoskeletal system [42]. Major benefits of OpenSim are: (1) the ability to 
create subject-specific models of motion, (2) its ability to analyze experimental motion 
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capture data in all three planes, (3) the ability to calculate joint moments and powers, and 
(4) the ability to create forward dynamic simulations of walking. It is for the first two 
reasons that OpenSim was chosen as the analysis tool for the amputee data set. 
 
The first step in assessing a subject’s motion is to first scale the general musculoskeletal 
model to match the anthropometry (physical measurements) of an individual subject. The 
dimensions of each body segment are scaled based on relative distances between pairs of 
markers obtained experimentally and those of the corresponding virtual marker locations 
in the model (Figure 1.2). In this model, the torso is defined as a rigid body from the 
bottom of the spinal column to the top of the skull.  To simplify the model further, there 
are also no arms present. The knees and ankles are defined as one-degree of freedom 
joints, while the hips, pelvis, and torso have three-degrees of freedom. 
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Figure 1.2: Scaling the Generic Model in OpenSim. Experimental markers are indicated 
in blue, while virtual model markers are pink. 
 
Once the model has been scaled to match an individual subject, joint angles and positions 
can be determined for each experimental trial. This step is referred to as performing 
inverse kinematics. In OpenSim, this step is formulated as a least-squares problem which 
minimizes the difference between the measured marker location and the model’s virtual 
marker locations. Therefore, in each frame of the experimental data, the weighted 
squared error is minimized. 
 ( )2markers subject model
1
i i i
i
Squared Error w x x
=
= −∑ JK JK  (1) 
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In this equation, 
subject
ix
JK
and 
model
ix
JK
are the three-dimensional positions of the ith marker 
for the subject and model, respectively, and iw is a factor which allows different markers 
to be weighted differently. Weighting is used to put relative weights on each of the 
different markers. For example, boney landmarks (i.e. knees, ankles, anterior superior 
iliac spine) are given greater weightings than fleshy landmarks (i.e. thighs or calves) 
because the degree of certainty for correct marker placement is higher. Because the 
weight values are relative, a value of 1 for a fleshy marker compared to a value of 10 for 
a boney maker would have the same effect as putting vales of 0.1 and 1, respectively. 
When the weighted squared error is minimized, the coordinate values which produced 
this error are reported for the frame. Once the coordinate values have been determined for 
every frame, the trial results are then exported into MATLAB for statistical analysis. 
 
1.6. THESIS ORGANIZATION 
 
Chapter 2 of this thesis covers the refinement of a gait analysis technique, piecewise 
linear length normalization (PLLN). This study examined how specific gait events, which 
align with traditional subphases of the gait cycle, can be used as points of interest in 
PLLN. This study used data from healthy adult males in both normal walking conditions 
and with a simulated impairment caused by the addition of a restrictive knee-brace. 
Chapter 3 evaluates the kinematic performance of amputees prior to and after a special 
training program. The results were analyzed using standard spatiotemporal metrics, 
OpenSim, and PLLN. Chapter 4 summarizes the findings and explores potential future 
work and experiments. 
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CHAPTER 2: PIECEWISE LINEAR LENGTH NORMALIZATION USING GAIT 
EVENTS 
 
2.1. INTRODUCTION 
 
Time normalization of kinematic, kinetic, and/or electromyography (EMG) gait data to 
percent gait cycle is a common practice of assessing average behavior over several gait 
cycles, or comparing gait patterns from different populations. This process assumes that 
gait cycles are periodic and assigns consecutive ipsilateral heel-strikes to 0 and 100% gait 
cycle, respectively. This approach generally ignores timing variability in movement 
patterns, both between and within gait cycles, e.g., variations in peak value times or toe-
off times. Thus movement data averages over multiple gait cycles may express reduced 
peak magnitudes and results in increased standard deviations due to inter- and intra-cycle 
variability in timing [1, 2]. 
 
Although gait researchers often acknowledge these alignment problems, relatively few 
studies have attempted to address them. If used, separation between stance and swing 
phases by aligning data to toe-off is the most common approach. A few have tried 
aligning gait data at multiple instances throughout the gait cycle, such as peak values [1], 
arbitrary states [2], or across the entire gait cycle [3]. These works did not consider 
alignment based on clinically-relevant gait events that identify sub-phases of the gait 
cycle, which may have resulted in overlooking subtle gait characteristics present in the 
data. Alignment by gait events could also allow comparison across joints and gait 
parameters, which may not be possible with the other techniques. Further, these works 
were interested in reducing temporal differences in order to better explore intensity 
differences in gait parameter magnitudes. They did not consider that additional 
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information from the system may be obtained by examining the temporal shifts (i.e. 
changes in timing) necessary to make these alignments.  
 
We recently explored multiple methods for time normalizing gait data and have found 
piecewise linear length normalization (PLLN) to be a preferable technique for removing 
timing variability between discrete points of interest throughout the gait cycle [4]. PLLN 
is essentially curve registration that compresses or expands the time axis of a cycle to-be-
aligned with a target data set. Alignments are done using linear interpolation between 
specified points of interest along the gait cycle. 
 
In this paper, we time normalized gait data using PLLN to specific gait events, as based 
on sub-phases of the gait cycle. We also illustrate the potential utility of examining 
temporal shift-signatures, i.e., temporal differences which highlight the direction and 
magnitude of temporal shifts necessary for alignment.  
 
 
2.2. METHODS 
 
2.2.1. Participants 
 
Walking data from ten healthy males, age 21 ± 2 (SD) years, height 1.79 ± .09 meters, 
and mass 81 ± 9 kg participated in the study [5]. Subjects had no gait impairments or 
history of significant injury to the lower limbs or joints. All subjects were also 
experienced treadmill walkers, and indicated right leg dominance. All procedures were 
approved by the University Institutional Review Board, and all participants gave 
informed consent. 
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2.2.2. Experimental Procedure 
 
Kinematic data were collected using a six-camera infrared camera system (VICON, 
Oxford, UK; Model 460) sampling at 120 Hz, and were filtered using a low-pass, fourth-
order Butterworth filter. Force data were captured continuously during the three-minute 
trials while the subjects walked on a treadmill (Proform, Logan, UT, USA; Model 
PFTL05052) for each testing condition. The subjects walked at a self-selected speed 
under two conditions: (1) normal, non-braced, and (2) braced right knee.  The addition of 
the knee brace (DonJoy, Vista, CA, USA; model 81,099) simulated an injury or other 
irregular gait pattern by preventing knee flexion. Sagittal plane joint angles, joint centers, 
and centers of mass were calculated from the motion capture data 
 
2.2.3. Piecewise Linear Length Normalization 
 
2.2.3.1. Defining the Gait Events for use in Normalization 
 
We defined seven sub-phases of gait from eight gait events (Figure 2.1) [6]. Loading 
response (LR) was defined as ipsilateral heel strike (IHS1) to contralateral limb toe-off 
(CTO). Mid-stance (MS) was defined as CTO to weight alignment over the forefoot 
(WA), which occurred when the center of mass of the torso was aligned with the joint 
center of the ipsilateral toes. Terminal stance (TS) lasted from WA until contralateral heel 
strike (CHS). CHS began pre-swing (PS), which lasted until ipsilateral toe-off (ITO). 
Initial Swing (ISw) began at ITO and continued until the ipsilateral toe was aligned with 
the contralateral heel (THA). THA indicated the beginning of Mid-Swing (MSw), which 
continued until the sagittal plane ipsilateral knee aligned with the ipsilateral ankle (KA).  
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Terminal swing (TSw) then began, and continued until the ipsilateral heel again struck 
the ground (IHS2). 
 
 
Figure 2.1: The seven sub-phases of gait as based on gait events: Loading Response 
(LR), Mid-Stance (MS), Terminal Stance (TS), Pre-Swing (PS), Initial Swing (ISw), Mid-
Swing (MSw), and Terminal Stance (TSw).  
 
 
2.2.3.2. Creating the Consensus Curve 
 
A consensus data set was created from the un-braced angle data, by determining the 
average timing, in % gait cycle, for each gait event of the un-braced data sets. Two 
matrices, one for each side (left and right), were created for each subject with the rows 
representing each cycle, and each of the eight columns containing the frame index for 
each gait event. The time, in frames, for each of the sub-phases was then calculated for 
each of the gait cycles. The timings for each sub-phase of each cycle were then converted 
into a percentage of the total gait cycle. These values were then averaged and used to 
create a subject-specific timing matrix. 
 
Once the average timings for each subject were calculated, it was possible to determine 
consensus average timings across all subjects (Table 2.1).  These consensus timings were 
then used to linearly warp each trial’s kinematic curves for a given subject.  For example, 
if a subject spent, on average, 14% of the gait cycle in loading response, but the 
consensus timing was 18%, the time scale for this subject’s loading response was linearly 
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shifted to match the consensus value.  Once all of a subject’s un-braced gait cycles were 
warped to the consensus timing values, the curves (e.g. ankle, knee, and hip) were 
averaged to create an average curve for the given subject. The mean of the ten subjects’ 
average curves became the consensus curve (Figure 2.2).  
 
2.2.3.3. Aligning the Knee-Braced Data 
 
The average timings for each of the sub-phases were found for the braced data in the 
same manner as that of the un-braced data. These values were recorded for use in the 
temporal shift calculations.  The consensus values from the un-braced data set, 
recognized as the normative values, were then used to align each subject’s braced 
kinematic curves, and these newly aligned curves were then averaged to generate a 
subject’s characteristic braced curves (Figure 2.2). Temporal and intensity differences 
(test minus target values) for each subject’s curve relative to the consensus curve were 
then calculated. 
 
2.3. RESULTS 
 
Average timings for the gait events for both the un-braced and braced data set for both 
right and left legs can be seen in Table 2.1. 
Table 2.1: Consensus timings (± standard deviation) for subphases across all subjects, 
both left and right legs. Reported are the consensus timings for the unbraced data (in % 
Gait Cycle) and the average braced data timings prior to alignment by PLLN. 
 
Right 18.1 ± 1.1 13.8 ± 1.8 18.0 ± 2.0 18.0 ± 0.9 9.6 ± 0.8 15.3 ± 1.1 7.2 ± 2.2
Left 18.1 ± 1.1 13.4 ± 1.8 18.5 ± 1.6 18.5 ± 1.1 9.5 ± 0.7 9.2 ± 1.1 13.2 ± 2.6
Right 14.5 ± 1.0 11.2 ± 2.6 20.2 ± 2.3 15.5 ± 3.4 12.5 ± 3.4 16.1 ± 0.7 10.0 ± 2.4
Left 15.6 ± 2.0 14.9 ± 3.0 23.4 ± 2.1 14.5 ± 1.0 9.1 ± 1.3 9.1 ± 1.1 13.1 ± 2.9
Unbraced
Braced
Initial Swing Mid-Swing Terminal SwingTrial Leg
Loading 
Response Mid-Stance
Terminal 
Stance Pre-Swing
 
 
As can be seen from the table, bracing resulted in noticeable average temporal shifts. For 
the right, braced leg, there were significant changes in every subphase of gait (p<0.05), 
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with an decrease of 20% in loading response, 19% decrease in mid-stance, 12% increase 
in terminal stance, 14% decrease in pre-swing, 30% increase in initial swing, 5% increase 
in mid-swing, and 39% increase in swing. Meanwhile, the left leg showed significant 
temporal changes in loading response, terminal stance, and pre-swing, with an decrease 
of 14%, increase of 26%, and decrease of 22%, respectively. Bracing also had an impact 
on the degree of symmetry between the limbs. Prior to bracing, both legs were nearly 
symmetrical in phase timing, with only the mid-swing and terminal-swing phases 
showing significant differences between the legs (p<0.05).  After bracing, however, 
significant asymmetries were present between the two limbs in all but loading response 
and pre-swing phases. For example, the average difference between the limbs in initial 
swing prior to bracing was only 0.1 % GC, while after bracing, the difference was 3.4 % 
GC.  
 
Bracing also had a significant impact on the shape of the kinematic curves, and PLLN 
improved the alignment of the motion patterns (Figure 2.2). It is important to note that 
even after alignment by PLLN, the peak values of the joint angle curves do not align. 
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Figure 2.2: Sample subject trajectories for the right leg ankle, knee, and hip sagittal 
plane joint angles. Shown curves are averages of forty gait cycles from one subject, with 
the exception of the black solid line, which is the consensus curve (all curves from all 
subjects after PLLN alignment). The other curves represent the knee-braced before (red 
dashed) and after (blue solid) alignment using PLLN. Vertical dashed lines indicate key 
consensus gait event timings. 
 
 
The intensity and temporal differences for all ten subjects were calculated, and a 
representative curve can be seen in Figure 2.3. This particular subject spent 4% less time 
(in % GC) in loading response when the knee was braced as compared to the average 
unbraced data (i.e. this subject spent an average of 14% of the gait cycle in loading 
response when the right knee was braced).  This particular subject also spent 2% more 
time in terminal stance and 2 % more time initial swing when the right knee was braced 
than the consensus unbraced average. 
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Figure 2.3: Intensity and temporal differences for the right side of one subject. Intensity 
plots are given for the right ankle (solid green), knee (solid red), and hip (solid purple). 
 
Alignment with PLLN significantly changed the intensity differences for each kinematic 
curve when compared to the unwarped data (Figure 2.4). For example, in the right ankle 
curves, the maximum intensity difference decreased by 3.5° in the warped curve as 
compared to the unwarped curve, while the minimum intensity difference increased by 
8.3°.  
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Figure 2.4: Changes in intensity differences between the warped and unwarped data set 
in one subject. Dashed lines indicated unwarped data, while heavy solid lines represent 
intensity differences after alignment using PLLN. Vertical dashed lines indicate timing of 
consensus gait events. 
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2.4. DISCUSSION 
 
Use of the PLLN technique provided additional insight into the effect of bracing one knee 
in healthy adult males by giving more detailed information about temporal shifts in gait 
patterns. The right, braced leg showed a decreased time spent in loading response, mid-
stance, and pre-swing (20%, 19%, 14%, respectively), and an increased time in terminal 
stance, initial swing, mid-swing, and terminal swing (12%, 5%, and 39%, respectively) as 
compared to the unbraced trials (see Table 2.1 for changes in terms of % GC). The left 
leg showed a 14% decrease in the loading response phase and a 26% increase in terminal 
stance and 22% increase in pre-swing. Each of these changes represented a physical 
adaptation to the perturbation caused by the knee brace.  For example, a decreased time 
in loading response indicates a need for faster weight acceptance, while a decrease in 
mid-stance and pre-swing implies the individuals are progressing over their stationary 
foot faster, and wish to transfer their weight to the other limb earlier. The asymmetries 
evident between the limbs indicated a desire of the subjects to spend more time in stance 
on the unbraced limb when compared to the braced limb, and more time in swing on the 
braced side. The temporal data also indicated the braced data typically led comparable 
events in the consensus data for that side, while the unbraced side remained relatively 
constant between the two conditions. 
 
Alignment of the motion patterns was also improved through the use of PLLN (Figure 
2.2). The improved alignment allowed for examination of intensity differences in the 
three joint angles throughout the gait cycle, rather than at specific points as commonly 
reported. By using gait events to normalize the data, it is possible to align the data across 
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all the joint angles, which would not be possible if the peaks of one kinematic profile 
were chosen as the points of interest during normalization. One final observation is that 
after alignment by PLLN, the peaks of the joint angle curves, especially apparent in the 
ankle joint, do not align to the consensus curves, which may provide greater clinical 
relevance to the interpreted data. 
 
2.5. CONCLUSIONS 
 
By specifically selecting clinically-relevant gait events, it may be possible to provide 
improved interpretation of gait behaviors, especially behaviors that deviate from 
normative patterns. By capturing and examining the temporal differences that were 
necessary to expand or contract the time axis of the given cycle relative to the consensus 
pattern, we are provided with greater insight into more subtle timing differences within 
the gait cycle. These timing differences may provide useful information about impaired 
control mechanisms of gait. 
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CHAPTER 3: THE EFFECT OF A HIP STRENGTH IMPROVING PROGRAM 
ON GAIT IN LOWER-LIMB AMPUTEES 
 
 
3.1. INTRODUCTION 
 
It is well-documented that amputee gait tends to be distinctly different from able-bodied 
gait.  In general, amputees have a slower self-selected comfortable walking speed, 
decreased stride length, decreased cadence, and increased cycle time [1-6]. Amputee gait 
also displays a high degree of asymmetry between the prosthetic and sound limbs. Step 
time, swing time, and step length tend to be longer, while stride length and stance time 
are shorter on the prosthetic side as compared to the intact limb [3, 5]. In general, the 
sound limb carries more weight than the amputated limb; although, the weight bearing 
capacity on the prosthetic side has been found to increase as the strength of the residual 
muscles increases [7]. The increased and repetitive loading on the intact limb during 
walking can lead to pain and joint degradation in the intact limb [8, 9]. 
 
It has also been observed that amputees with highly atrophied hip-stabilizing muscles in 
the residual limb walked with an extreme lateral bending of the trunk during swing, thus 
the relative strength of the thigh muscles directly contributes to the metabolic cost of 
walking in amputees [2, 7, 10-12]. It has been widely documented that lower-limb 
amputees display a progressive decrease in muscle strength over time, as well as a 
progressive increase in muscle atrophy, primarily in the residual limb [13-17]. This 
muscle atrophy has been associated with changes in gait strategy and the loss of ability to 
strongly contract the distal muscles of the residual limb.  
 
29  
Other studies have shown that strong hip muscles correlate strongly with improved gait 
performance, as well as decreased pelvic tilt and out-of-plane movement of the torso [2, 7, 
10]. This leads to the supposition that by increasing the hip strength of amputees, it is 
possible to improve gait performance, potentially decrease the metabolic cost associated 
with walking, and even prevent joint degradation through reducing asymmetrical loading 
[18-20]. 
 
Because of the compensatory strategies mentioned above, as well as the physiological 
changes due to amputation (i.e. muscle atrophy), amputees tend to display decreased 
endurance, increased fatigue while walking, and feel unable to run and jump [21]. Thus, 
they do not participate in recreational and sports activities. By designing a training 
program for lower limb amputees to strengthen muscles which are usually weak, it may 
enable running in individuals who may otherwise feel unable to participate in recreational 
activities.  
 
Hip strengthening programs have been used to improve gait, but not necessarily running, 
in other populations. For example, a study done on children with Cerebral Palsy showed 
that strength training of the hip and knee extensors could improve walking function and 
alignment in patients with whom weakness was the major contributor to gait deficiencies 
[22]. The effect of strengthening the hip and knee flexors has been assessed in patients 
with hemiparesis, which is the unilateral weakness of the body [23, 24]. These studies 
have shown that as the strength of the affected plantarflexors and hip flexors increased, 
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the participants’ walking speeds increased and their maximal levels of effort decreased 
when compared to the pre-training data.  
 
Muscle strengthening programs have been used successfully in amputees. One study used 
isometric strength training to improve muscle volume and strength in the residual limb of 
transtibial amputees. This training resulted in better prosthesis retention during walking, 
and a decrease in time spent in swing on the prosthetic limb [25]. Another study used 
isokinetic strength training in transtibial amputees, with the result of improved muscle 
strength in the knee extensors of the residual limb and patient-reported improvements in 
gait [14].  A third study combined psychological and physiotherapeutic treatment to 
improve gait in transfemoral amputees.  This particular study was aimed at integrating the 
prosthesis into normal movements and increasing body-awareness.  This study ultimately 
showed that when the subject’s comfortable walking speed increased, there was more hip 
joint symmetry, more muscle work was done on the amputated side, and lower back pain 
disappeared [6, 26].  Therefore, because hip strengthening programs in other populations, 
and muscle strengthening programs in amputees, have shown success in improving gait 
performance, a hip strength improving program should have a beneficial impact on the 
gait of lower-limb amputees. 
 
The goals of this project were to determine the plausibility of using a hip strength 
improving program to improve kinematic performance, decrease the metabolic cost 
associated with walking, and determine if the training is sufficient to enable running in 
lower-limb amputees. Seventeen subjects were randomly separated into a no-intervention 
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control group and a hip strength training group. An initial study found that, for 
participants of the training group, the hip strength was improved, oxygen consumption 
decreased, and only one subject was not able to run after the ten week training period 
[27]. In the control group, either no changes were observed, or in some cases, muscle 
strength decreased and oxygen consumption increased. The study presented in this paper 
examines whether there were changes in kinematic walking gait metrics as a consequence 
of the hip strengthening program and also if there were changes in gait between subjects 
that were eventually able to run versus those that could not. 
 
3.2. METHODS 
The experimental protocol for the training program can be found in [27]. Participant 
demographics, experimental procedure as it relates to kinematic performance, and the 
data analysis techniques used in the thesis will be briefly summarized. 
 
3.2.1. Participants 
Seventeen lower-limb amputees were included in this study, assigned to either a control 
(n = 8) or training group (n = 9). Participants were matched as closely as possible by 
gender, level of amputation, and number of years as an amputee. Of the eight in the 
control group, three were transtibial (TT) and five were transfemoral (TF), while in the 
training group, four were TT, three were TF, and two were bilateral, one side TF and the 
other side TT. The data from the two bilateral training group amputees are not included in 
this analysis. All participants had amputations resulting from tumor, trauma, or 
congenital problems and all walked with their prosthesis daily.  All participants were 
amputees for at least one year prior to the study. The mean age (± standard deviation), 
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height, body mass, and years as an amputee were 41.1 ± 8.4 years, 1.8 ± 0.12 meters, and 
91.5 ± 25.5 kg, and 8.2 ± 9.2 years, respectively for the training group. The control group 
had a mean age, height, body mass, and years as an amputee of 49.0 ± 9.1 years, 1.7 ± 
0.08 meters, and 76.2 ± 14.9 kg, and 8.3 ± 11.3 years, respectively (for detailed subject 
descriptions, see Table 3.12 in Appendix A). Ethical approval for the study was granted 
by the Karolinska Institutet (Sweden) Regional Ethics committee and written informed 
consent was obtained from all the participants. 
 
3.2.2. Experimental Procedure 
All amputees participated in the same pre- and post- assessments.  The control group 
continued with the same form and amount of exercise they had been doing regularly for 
the three months prior to study participation, and had their post-test assessment 10 weeks 
after their pre-test assessments. Meanwhile, the training group went on to complete 10 
weeks of the training program described in [27], and their post-training assessment was 
performed within two days of completing the training.  
 
Testing consisted of isokinetic muscle testing, overground walking trials, and oxygen 
consumption treadmill walking trials performed at the same speed as the overground 
trials. Three-dimensional motion capture was used during the over ground walking trials 
(ProReflex, Qualysis, Sweden), sampled at 240 Hz.  Twenty-three reflective markers 
were placed on the body, with the markers on the prosthetic limb placed to correspond 
with the markers on the intact limb (Figure 3.1).  Ground reaction forces were captured 
using an AMTI force platform (Watertown, MA, USA), embedded in a walkway and 
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sampled at 240 Hz.  Individuals wore tennis shoes for the trial, and the same prosthesis 
was worn in both the pre- and post-assessments. Walking trials were repeated as 
necessary to get two good force plate recordings for both the intact and prosthetic limb, 
and subjects were asked to walk at approximately 1 m/s.  Subjects were allowed to rest 
between trials if they were fatigued.  Muscle testing scores and oxygen consumption 
values were recorded prior to gait trials, but will not be presented in this study [27]. 
 
Figure 3.1: Qualysis Bone Model showing the positions of the twenty-three reflective 
markers. 
 
 
During the pre-testing session, all participants were asked if they could run with their 
prosthetic limb, and if answered in the affirmative or were not sure, were asked to 
demonstrate. The ability to run was defined as continuous leg-over-leg running for at 
least ten seconds on the treadmill at a speed faster than the subject could walk. Only one 
member of the training group stated he was able to run previously, but upon 
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demonstration was only able to run leg-over-leg for less than three consecutive strides. 
Running ability was qualitatively assessed in the training group during the post-training 
assessment period using the same criteria. Those that wished to attempt running were 
strapped into a harness over a treadmill (Rodby, Vänge, Sweden), and instructed in a leg-
over-leg running technique [28]. The treadmill speed was slowly increased until the 
subject was forced to change from walking to slow jogging. They were allowed to stop 
and rest at any point if they felt fatigued. All running was attempted with the participant’s 
prosthesis set up for walking.  
 
3.2.3. Data Analysis 
3.2.3.1. Spatiotemporal Gait Characteristics 
The kinematic data were first analyzed by looking at standard temporal-spatial gait 
characteristics. These metrics included stride length and time, step length, time and width, 
stance time and swing time. Ten partially consecutive gait cycles for both the prosthetic 
and intact limb were randomly chosen from the available kinematic data. Because the 
force plate only captured one heel strike on one side of the body per trial, marker data 
were used to find subsequent heel strike and toe-off locations. Heel strike and toe-off 
locations were validated using force plate data, and it was determined that there was a 
constant offset for each subject caused by the compression of the sole of the shoe. This 
offset was taken into account when determining gait events (Table 3.12 in Appendix B). 
 
Initially, the results were separated by group, type, side, and session (Table 3.1).  Stride 
and step length were normalized to subject height. Symmetry index (SI) values were also 
calculated for each of the spatiotemporal characteristics using the expression [29]: 
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where I was the intact limb parameter and P was the prosthetic limb parameter. Negative 
SI values indicated that the parameter value for the prosthetic limb was greater than the 
intact limb. 
 
To gain more insight into the effect of the hip strengthening program, the outcome 
metrics described above were also separated by the ability of the subjects to run after 
training.  
 
3.2.3.2. Kinematic Profiles 
The kinematic profiles of the hip and pelvis were also investigated. Because amputees 
have displayed out-of-plane movement of the torso and pelvis [1, 2, 4], it was important 
not to limit the analysis of the kinematic data to only the sagittal plane.  To capture the 
three-dimensional motion at the hip, OpenSim was chosen as the tool to analyze the 
experimental data.  OpenSim is an open source musculoskeletal modeling program [30], 
which allows for subject-specific models to be created and analyzed.   
 
A generalized 8-link rigid body model, with 8 joints and 34 degrees of freedom, was first 
scaled to match experimental motion capture data. Inverse kinematics (joint angles and 
positions) were determined by solving a least-squares problem at each frame. This least-
squares problem minimized the difference between the measured marker location and the 
model’s virtual marker locations, as restricted to joint constraints. Ranges of motion 
(ROM) were calculated for the hip, pelvis, and torso, and separated in the same manner 
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as the spatiotemporal characteristics (testing session, testing group, prosthesis type, limb 
side, and running ability). Hip ROM was determined by hip flexion, and pelvis ROM was 
calculated by the vertical height of the pelvic center of mass. Symmetry indices for the 
hip flexion ROM were also calculated. 
 
3.2.3.3. Piecewise Linear Length Normalization 
The final analysis tool used on this data set was piecewise linear length normalization 
(PLLN). PLLN is a technique for segmenting gait data into subphases at points of interest 
and temporally aligning these points of interest for each test trajectory with the 
corresponding trajectory of the target point of interest [31].  For this data set, the points of 
interest were clinically relevant gait events, each defining boundaries for specific 
subphases of gait (see Chapter 2). Here,  five sub-phases of gait were determined from 
six gait events [32]. Loading response was defined as ipsilateral heel strike to 
contralateral limb toe-off. Mid-stance was defined as contralateral toe-off to weight 
alignment over the forefoot, which occurred when the center of mass of the torso was 
aligned with the joint center of the ipsilateral toes. Terminal stance lasted from weight 
alignment until contralateral heel strike. This gait event began pre-swing, which lasted 
until ipsilateral toe-off. Swing then continued until the subsequent ipsilateral heel strike. 
Once the average timings for each of the clinically relevant gait events were determined 
for each subject during both pre- and post- training, the results were grouped in the same 
manner as the spatiotemporal and kinematic results. The average timings for the different 
groups were then determined.  
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3.2.3.4. Statistical Analysis 
The major groupings analyzed were as follows: 1) testing group (training vs. control), 2) 
prosthesis type (TT or TF), 3) side (prosthetic or intact), 4) testing session (pre- vs. post), 
and 5) running ability (runner vs. non-runner). Statistical analyses were done as a 
Student’s unpaired or paired t-tests, with significance defined as p<0.05. Trends in the 
data were defined as 0.05 ≤ p <0.10. All statistical tests were performed in Excel. 
 
3.3. RESULTS 
3.3.1. Spatiotemporal Gait Characteristics 
3.3.1.1. Results from the Training and Control Groups 
Preliminary unpaired t-tests between training and control groups and within limb side 
found modest differences due in spatiotemporal gait parameters (Tables C.3a and C.3b in 
Appendix C). For the intact limb of TF subjects (Table C.3a), only average stance time 
differed significantly between groups and this was only at the start of the study (69.3 ± 
0.9 % gait cycle (%GC) for controls and 67.4 ± 1.5 %GC for training, p = 0.03). Also 
during pre-test, average step width tended to be larger for controls (0.17 ± 0.02 m) than 
training (0.13 ± 0.06m), p = 0.08. For the prosthetic limb, there were more differences 
between training and control group gait parameters for TF subjects than TT subjects 
(Table C.3b). During pre-test, average step length (p = 0.01) and average stance time (p 
=0.03) were significantly longer for TF training group subjects. These trends tended to 
remain post-training. Average step time tended to be shorter for the TF training group 
(0.66 ± 0.02s vs.  0.71 ± 0.04s, p = 0.07), but step time increased in the TF training group 
after training while there was no change for the control group (0.69 ± 0.01s vs. 0.71 ± 
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0.03s). For TT subjects, average step time on the prosthetic limb also tended to be longer 
for the TT training group before pre-test (p = 0.07) and this difference became 
significantly different post-test (p = 0.01); however, the statistical significance was 
mainly a result of smaller variance around the mean. 
 
Subsequent analyses were done by separately examining training from control group data. 
Results from paired t-tests between pre- and post-testing for each group and type found 
several significant differences in the standard metrics when the data were examined by 
limb, prosthesis type, and within a test group (Table 3.1, p<0.05). Specifically, the TT 
control group showed a 3% decrease in step length on the prosthetic side in the post-trials 
as compared to the pre-trials, while the TT training group showed a 3% increase in intact 
side stride length and 20% increase in intact limb step width post-training. Meanwhile, 
the TF training group took 5% greater stride time on their prosthetic side. There were 
some trends present in the data set, as well (0.05≤ p <0.10). The TT controls tended to 
spend 2% longer in stance and 2% shorter in swing on their intact side in the post- 
assessments, while the TF controls took 6% longer steps on their intact limb. In the 
training group, the TTs had a tendency to increase step time, by 3%, while the TFs had a 
2% longer stride time in the post-training sessions versus the pre-training. 
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Table 3.1: Table comparing spatiotemporal characteristics of group, type, side, and 
session. Described are mean values for  normalized stride length, stride time, normalized 
step length, step width, stance time (% Gait Cycle), and swing time (% Gait Cycle) for 
both the intact (I) and prosthetic (P) sides, with standard deviations. 
 
Pre 0.72 (0.06) 1.19 (0.07) 0.34 (0.04) 0.60 (0.04) 0.11(0.01) 65.2 (0.9) 34.8 (0.9)
Post 0.72 (0.05) 1.22 (0.08) 0.35 (0.02) 0.60 (0.06) 0.10 (0.03) 66.0 (1.6) 34.1 (1.6)
Pre 0.72 (0.06) 1.20 (0.06) 0.39 (0.02) 0.60 (0.05) 0.11 (0.02) 63.7 (0.9) 36.3 (0.9)
Post 0.71 (0.04) 1.20 (0.08) 0.38 (0.02) 0.61 (0.02) 0.13 (0.05) 63.1 (2.5) 36.9 (2.5)
Pre 0.71 (0.03) 1.30 (0.10) 0.35 (0.03) 0.59 (0.07) 0.17 (0.02) 69.3 (0.9) 30.7 (0.9)
Post 0.73 (0.03) 1.29 (0.09) 0.37 (0.03) 0.58 (0.07) 0.16 (0.01) 69.0 (1.1) 31.0 (1.1)
Pre 0.71 (0.03) 1.30 (0.09) 0.37 (0.01) 0.71 (0.04) 0.16 (0.03) 62.4 (1.9) 37.6 (1.9)
Post 0.73 (0.03) 1.29 (0.09) 0.36 (0.02) 0.71 (0.03) 0.16 (0.02) 61.2 (2.4) 38.8 (2.4)
Pre 0.67 (0.09) 1.26 (0.13) 0.34 (0.04) 0.59 (0.10) 0.10 (0.03) 68.4 (4.2) 31.6 (4.2)
Post 0.69 (0.09) 1.26 (0.10) 0.35 (0.03) 0.60 (0.10) 0.12 (0.04) 67.8 (3.4) 32.2 (3.4)
Pre 0.68 (0.09) 1.25 (0.14) 0.33 (0.05) 0.66 (0.04) 0.13 (0.03) 62.43 (2.8) 37.6 (2.8)
Post 0.69 (0.09) 1.26 (0.09) 0.34 (0.06) 0.66 (0.01) 0.10 (0.05) 63.1 (3.1) 36.9 (3.1)
Pre 0.70 (0.06) 1.28 (0.08) 0.32 (0.04) 0.62 (0.06) 0.13 (0.06) 67.4 (1.5) 32.6 (1.5)
Post 0.69 (0.04) 1.32 (0.05) 0.32 (0.05) 0.62 (0.03) 0.13 (0.06) 68.3 (0.9) 31.7 (0.9)
Pre 0.69 (0.05) 1.26 (0.08) 0.37 (0.02) 0.66 (0.02) 0.14 (0.05) 65.2 (1.4) 34.8 (1.4)
Post 0.70 (0.05) 1.29 (0.05) 0.38 (0.01) 0.69 (0.01) 0.13 (0.05) 64.0 (2.6) 36.0 (2.6)
Norm. Stride 
Length (m)
Avg Stride 
Time (s)
Avg Stance 
Time (%GC)
Avg Swing 
Time (%GC)
Norm. Step 
Length (m)
Avg Step Time 
(s)
Avg Step Width 
(m)
Controls
TT
I
P
TF
I
P
Training
TT
I
P
TF
I
P  
Pink cells indicate significant differences between pre and post-test and within a test group, prosthesis 
type, and limb side using a paired t-test (p<0.05), while orange cells indicate borderline significance 
between pre and post (0.05≤ p <0.1) 
 
The symmetry index (SI) values for certain standard gait metrics were found to 
significantly change (p<0.05) between pre- and post-testing for all control subjects, while 
borderline significant trends (0.05≤p<0.10) were observed in the training group (Table 
3.2). For the control group, statistically significant changes in the directionality of 
movement symmetry were noted for stride time and step width (pink shading, p<0.05). 
Specifically, TT controls changed from longer stride times on the prosthetic side during 
the pre-trials to longer stride times on the intact side after 10 weeks. TF controls used 
greater step widths on the intact side at baseline and greater widths with the prosthetic 
side after 10 weeks. The TT training group, on the other hand, showed an opposite 
borderline significant trend such that the asymmetry in step width changed from wider 
steps on the prosthetic side before training to wider steps on the intact side after training 
(orange shading, 0.05≤ p <0.10). Training also seemed to reduce the asymmetry in step 
width for TF subjects. Further, control subjects showed trends toward more symmetrical 
40  
step lengths over time, while TT training subjects showed an increasing trend in 
symmetry in both stance and swing time. 
 
Table 3.2: Symmetry index values for standard metrics, separated by group, type, and 
session. 
 
Pre 0.22 -0.78 -13.68 -1.32 -1.95 2.39 -4.34
Post 1.30 1.07 -7.81 -3.20 -23.14 4.48 -8.01
Pre -0.23 0.60 -5.56 -18.40 9.31 10.57 -20.21
Post 0.10 -0.04 0.68 -19.83 -5.14 11.92 -22.03
Pre -0.59 0.30 3.75 -12.04 -29.34 9.07 -17.69
Post 0.03 0.08 2.38 -10.19 17.97 7.12 -13.59
Pre 1.80 1.24 -14.37 -6.68 -12.02 3.35 -6.59
Post -0.36 1.83 -15.55 -10.79 -5.07 6.47 -12.39
Avg Swing 
Time
Avg Step 
Width
Avg Stance 
Time
Avg Stride 
Time
Norm. Step 
Length
Avg Step 
Time
Norm. Stride 
Length
AVERAGE SYMMETRY INDEX VALUES FOR STANDARD METRICS
Controls
TT
TF
Training
TT
TF
 
Negative SI values indicate that the prosthetic limb value was greater than for the intact limb. Pink 
cells indicate significant differences between pre- and post (p<0.5), while orange cells indicate 
borderline significance between pre- and post- (0.05≤ p <0.1). 
 
3.3.1.2. Runners vs. Non-runners Comparison 
Because an additional aim of the study was to determine if the training program was 
suitable to develop sufficient strength to enable running, the data were separated by 
ability to run after training (Table 3.3). Of the seven members of the training group (4 TT, 
3 TF), only one TT subject was unable to run after training. By separating the data in this 
manner, other significant differences in overall kinematic behavior pre- and post-training 
became apparent. On average for the non-runners, step length increased by 3% on the 
intact limb; while on the prosthetic limb, swing time increased and stance time decreased 
by 3%. In the runners, average step width increased by 19% on the intact side in the post-
trials as compared to the pre-trials. Symmetry index values were also calculated between 
the limbs for this grouping, but they showed no significant or border-line significant 
trends (Table 3.4). 
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Table 3.3: Table comparing spatiotemporal characteristics of running condition, side, 
and session. Described are normalized stride length (m), stride time (s), normalized step 
length (m), step width (m), stance time (% Gait Cycle), and swing time (% Gait Cycle) for 
both the intact (I) and prosthetic (P) sides, with standard deviations. 
 
Pre 0.70 (0.07) 1.25 (0.10) 0.34 (0.03) 0.58 (0.07) 0.14 (0.04) 68.3 (2.7) 31.7 (2.7)
Post 0.71 (0.07) 1.25 (0.09) 0.35 (0.03) 0.58 (0.07) 0.13 (0.04) 68.2 (2.1) 31.8 (2.1)
Pre 0.70 (0.07) 1.24 (0.10) 0.36 (0.04) 0.67 (0.06) 0.14 (0.03) 62.6 (1.7) 37.4 (1.7)
Post 0.70 (0.06) 1.25 (0.09) 0.36 (0.04) 0.67 (0.05) 0.14 (0.05) 61.6 (2.5) 38.4 (2.5)
Pre 0.71 (0.04) 1.29 (0.10) 0.34 (0.04) 0.62 (0.07) 0.11 (0.05) 67.2 (2.6) 32.8 (2.6)
Post 0.71 (0.04) 1.30 (0.07) 0.34 (0.04) 0.63 (0.06) 0.13 (0.05) 67.5 (2.4) 32.5 (2.4)
Pre 0.70 (0.04) 1.28 (0.10) 0.37 (0.02) 0.67 (0.03) 0.13 (0.04) 64.1 (2.4) 35.9 (2.4)
Post 0.71 (0.04) 1.29 (0.06) 0.37 (0.02) 0.68 (0.02) 0.12 (0.04) 64.2 (2.1) 35.8 (2.1)
Avg Step 
Width (m)
Avg Stance 
Time (%GC)
Avg Swing 
Time (%GC)
Avg Stride 
Time (s)
Avg Step 
Time (s)
Norm Stride 
Length (m)
Norm Step 
Length (m)
Non- Runners
Runners
I
P
I
P
 
Pink cells indicate significant differences between pre- and post (p<0.5). 
 
 
Table 3.4: Symmetry index values for standard metrics, separated by running condition 
and session.  
 
Pre -0.07 0.15 -6.33 -13.67 -1.48 8.69 -16.72
Post 0.46 0.28 -0.38 -14.89 -5.17 10.09 -18.58
Pre 0.52 0.71 -6.67 -6.85 -16.57 4.68 -9.02
Post -0.12 1.04 -8.96 -7.98 1.34 5.02 -9.75Runners
AVERAGE SYMMETRY INDEX VALUES FOR STANDARD METRICS
Avg Stride 
Time (s)
Norm. 
Step 
Norm. 
Stride 
Non- Runners
Avg Step 
Time (s)
Avg Step 
Width (m)
Avg 
Stance 
Avg Swing 
Time 
 
 
 
Prior to the training period, no subject was able to run on the treadmill. After training, all 
but one subject of the training group was able to run continuously for ten seconds on the 
treadmill. This one subject’s spatiotemporal behaviors were very different from the others 
who could run (see Table C.6 in Appendix C). The normalized stride lengths of both 
limbs of this subject fell three standard deviations (SD) outside the mean range of the 
runners, while stride time for both limbs was outside by one SD. Interestingly, while the 
normalized step length of the intact limb fell within the range of the runners, the 
prosthetic limb step length of this subject was shorter by five SDs. Other interesting 
trends in this subject as compared to the runners was that while the intact limb became 
more like the runners in stance and swing (from two SD outside of the norm during 
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baseline to one SD outside post training) in the post trials, the prosthetic limb became less 
similar (i.e., one SD pre-test to two SD post-test) in both parameters. 
 
 
3.3.2. Kinematic Profiles 
3.3.2.1. Results from the Training and Control Groups 
The hip flexion range of motion comparing group, type, side and session can be seen in 
Table 3.5. The intact side hip flexion ROM of the TF control group increased by 18%, 
while the prosthetic side hip flexion of the TF training group showed a tendency to 
increase their hip flexion by 8%. Symmetry indices showed no significant differences 
between sessions in either of the groups or types. The pelvic COM range of motion 
results are given in Table 3.6. In the first grouping, there was a significant decrease of 
15% in the TT control pelvic motion, while there was an increase of 9% in the pelvic 
COM motion of the TF training group.   
 
Table 3.5: Comparison the hip flexion range of motion, in degrees (with standard 
deviation), with group, type, side and session. 
 
Pre 40.1 (3.1)
Post 40.7 (6.8)
Pre 39.9 (8.1)
Post 40.9 (7.8)
Pre 38.7 (6.7)
Post 47.3 (4.6)
Pre 42.5 (3.0)
Post 40.8 (5.8)
Pre 40.5 (2.1)
Post 43.5 (4.0)
Pre 40.4 (9.8)
Post 42.0 (7.0)
Pre 43.9 (7.9)
Post 48.7 (3.3)
Pre 36.1 (6.4)
Post 39.4 (8.9)
HIP FLEXION RANGE OF MOTION (DEGREES)
Training
TT
I
P
TF
I
P
Controls
TT
I
P
TF
I
P
 
Pink cells indicate significant differences between pre and post (p<0.05), while orange cells indicate 
borderline significance between pre and post (0.05≤ p <0.1) 
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Table 3.6: Pelvic COM Range of Motion, arranged by group, type, and session.  
 
Pre 0.047 (0.004)
Post 0.041 (0.002)
Pre 0.056 (0.010)
Post 0.060 (0.008)
Pre 0.049 (0.003)
Post 0.047 (0.005)
Pre 0.050 (0.005)
Post 0.055 (0.001)
PELVIS COM RANGE OF MOTION (m)
Training
TT
TF
TT
TF
Controls
 
Pink cells indicate significant differences between pre and post (p<0.05), while orange cells indicate 
borderline significance between pre and post (0.05≤ p <0.1) 
 
3.3.2.2. Runners vs. Non-runners Comparison 
When the hip flexion ROM was separated by running capability (Table 3.7), the only 
significant change occurred in the non-runners, with an 11% increase in the ROM of their 
intact limb. The running group showed an increased trend of 9% and 4% for the intact 
and prosthetic limbs, respectively. Comparing the hip flexion of the single non-runner in 
the training group to the remainder of the runners, the intact side hip flexion in the post 
training trials and the prosthetic side hip flexion during both assessments fell 1SD outside 
of the running group averages (see Table D.4 in Appendix D). 
 
Table 3.7: Table comparing the hip flexion range of motion, in degrees with running 
condition, side, and session (with standard deviations). 
 
Pre 39.3 (5.0)
Post 44.5 (5.8)
Pre 39.9 (6.7)
Post 39.9 (6.3)
Pre 42.3 (5.6)
Post 46.4 (4.4)
Pre 40.5 (7.0)
Post 42.3 (6.8)
Runners
Non- Runners
I
P
I
P
HIP FLEXION RANGE OF MOTION (DEGREES)
 
Pink cells indicate significant differences between pre and post (p<0.05), while orange cells indicate 
borderline significance between pre and post (0.05≤ p <0.1) 
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Separating the groups into runners vs. non-runners showed no significant differences in 
the pelvic COM ROM between conditions (Table 3.8). The single non-runner of the 
training group had a pelvic COM motion that in the pre-trials fell 1 SD outside of the 
runners, while in the post-training trials fell within the normal range (see Table 3.24 in 
Appendix D). 
 
Table 3.8: Tables with pelvis COM locations, in meters (standard deviations),  with (1) 
group, type, side, and session, and (2) running condition, side, and session. 
 
Pre 0.052 (0.009)
Post 0.052 (0.011)
Pre 0.050 (0.003)
Post 0.051 (0.006)
Runners
PELVIS COM RANGE OF MOTION (m)
Non-Runners
  
 
3.3.3. Piecewise Linear Length Normalization 
3.3.3.1. Results from the Training and Control Groups 
PLLN showed several significant differences pre- and post- training in only the control 
group; there was no change in the gait event timings in the training group (Table 3.9). 
Significant differences included a 4% decrease in the amount of time spent in swing for 
the TT controls, and a 5% decrease in the amount of time spent in pre-swing in the TF 
controls, both on the intact limb. In terms of borderline significant changes, there was a 
4% increase in the amount of time spent in loading response on the prosthetic side of the 
TT controls, and a 3% increase in the amount of prosthetic swing on the TF controls.  
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Table 3.9: Timings of the subphases of gait as determined by PLLN. Data are arranged 
according to group, type, side, and session. All timing values are averages given in % 
gait cycle (with standard deviation). 
 
Pre 13.7 (0.6) 17.3 (1.5) 19.7 (2.1) 14.3 (1.5) 35.0 (1.0)
Post 14.0 (1.0) 19.3 (3.1) 17.7 (3.2) 15.3 (1.5) 33.7 (1.5)
Pre 14.7 (1.2) 18.7 (0.6) 16.7 (0.6) 14.0 (1.0) 36.0 (1.0)
Post 15.3 (1.5) 19.0 (3.5) 15.0 (2.0) 13.7 (0.6) 37.0 (2.6)
Pre 17.0 (3.0) 18.6 (6.2) 19.4 (5.9) 14.6 (2.2) 30.6 (0.5)
Post 16.0 (3.2) 19.0 (3.3) 20.2 (3.5) 13.8 (2.6) 31.0 (1.0)
Pre 14.4 (2.5) 17.8 (4.0) 13.0 (5.4) 17.0 (3.0) 37.8 (1.9)
Post 13.8 (2.6) 17.2 (4.3) 14.0 (4.7) 16.2 (2.9) 38.8 (2.4)
Pre 15.8 (3.2) 18.3 (3.8) 19.3 (1.0) 15.3 (2.9) 31.5 (4.2)
Post 15.5 (3.7) 17.8 (3.9) 19.8 (2.5) 15.0 (0.8) 32.0 (3.6)
Pre 15.0 (2.2) 16.8 (2.2) 15.3 (3.3) 15.8 (3.4) 37.3 (2.9)
Post 15.3 (1.3) 17.3 (3.6) 15.0 (2.6) 15.5 (3.7) 37.0 (3.4)
Pre 16.0 (2.6) 18.7 (1.5) 17.3 (2.9) 15.3 (1.5) 32.7 (1.2)
Post 16.3 (1.2) 17.7 (1.5) 18.3 (2.9) 16.0 (1.7) 31.7 (0.6)
Pre 16.0 (2.0) 22.0 (4.4) 11.3 (5.5) 16.3 (3.1) 34.7 (1.5)
Post 15.7 (1.2) 20.0 (5.2) 12.0 (4.4) 16.3 (2.1) 36.0 (2.6)
TF
Control
I
P
TT
Training
TT
I
P
TF
I
P
Loading 
Response Mid-Stance
Terminal 
Stance
I
P
Pre-Swing Swing
PLLN SUBPHASE TIMINGS (IN % GAIT CYCLE)
 
Pink cells indicate significant differences between pre and post (p<0.05), while orange cells indicate 
borderline significance between pre and post (0.05≤ p <0.1) 
 
 
3.3.3.2 Runners vs. non-runners Comparison 
In the grouping by running ability, the only significant difference occurred in the 
prosthetic side swing phase (Table 3.10). The non-runners spent 3% more time in swing 
on their prosthetic limb in the post trials. 
 
Table 3.10: Average timing lengths (with standard deviation) of the five subphases of 
gait as determined by PLLN. Data are arranged according to running condition, side, 
and session. All timing values are given in % gait cycle. 
 
Pre 15.9 (2.7) 18.7 (4.8) 19.3 (4.4) 14.6 (1.7) 31.7 (2.8)
Post 15.3 (2.5) 19.4 (3.0) 19.2 (3.2) 14.3 (2.1) 31.7 (1.9)
Pre 14.6 (1.9) 17.9 (3.0) 14.2 (4.3) 16.0 (2.6) 37.3 (1.8)
Post 14.3 (2.1) 17.6 (3.7) 14.3 (3.5) 15.3 (2.4) 38.4 (2.5)
Pre 15.7 (2.9) 17.7 (2.2) 18.5 (2.3) 15.3 (2.4) 32.8 (2.4)
Post 15.8 (3.0) 17.0 (2.4) 19.2 (2.8) 15.7 (1.2) 32.3 (2.4)
Pre 15.5 (2.2) 19.5 (4.2) 13.7 (4.9) 15.8 (3.3) 35.7 (2.5)
Post 15.7 (1.0) 19.0 (4.3) 13.7 (3.8) 15.8 (3.2) 35.8 (2.3)
Non-Runners
Runners
Loading 
Response Mid-Stance
Terminal 
Stance Pre-Swing Swing
I
P
I
P
 
Pink cells indicate significant differences between pre and post (p<0.05), while orange cells indicate 
borderline significance between pre and post (0.05≤ p <0.1) 
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The PLLN results from the single non-runner of the training group had several 
differences when compared to those who could run (see Table E.3 in Appendix E). The 
length of the loading response on the prosthetic limb decreased in the post training 
assessment. This change in timing also resulted in the non-runner taking spending less 
time in load than the runners by 1 SD. The length of mid-stance on the intact limb also 
remained longer than the runners’ normal average by 2 SD in both the pre- and post- 
assessments. Pre-swing on the intact limb became shorter, which moved the result from 
inside the range to 1 SD outside the normal. The intact side swing average moved from 2 
SDs outside of the normal range to 1, while the prosthetic side stayed 2 SDs outside of 
the normal runner range. 
 
 
3.4. DISCUSSION 
 
While the hip strengthening program did result in an improvement in hip strength and 
reduction in oxygen consumption for all members of the training group, these positive 
changes did not manifest in kinematic behaviors observed during walking. However, this 
trend is similar to findings in similar programs done on other populations [24, 33]. In a 
study by Milot et al., it was observed that while the strength of the hemiparetic limb 
plantarflexors and hip extensors increased dramatically after training, the participants did 
not change their habitual gait pattern, as seen in their kinematic and kinetic gait variables 
[24]. However, these subjects did show an increase in gait speed. In a similar manner, 
Ouelette et al. showed an improvement in strength, but no significant difference between 
the intervention and control groups for any performance-based measure [33]. It had been 
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suggested that by combining goal-oriented exercise with strength training, the outcome 
might have been different. This agreed with the findings by Sjödhal et al., which 
combined psychological and physiotherapeutic training in a special gait re-education 
program [34]. This study showed an improvement in gait symmetry and body weight 
distribution in lower-limb amputees, but suggested that in order to improve amputee gait, 
it was necessary to re-train the amputees how to walk, not simply strengthen their limbs. 
Because our study only emphasized strength training, it is probable that when the 
amputees walked, they maintained their learned gait behaviors.  
 
Although no significant spatiotemporal differences were observed in the training group, 
the hip strengthening program did successfully enable six of the seven training subjects to 
run. A study by Czerniecki and Gitter indicated that the hip-flexors and extensors of 
lower-limb amputee runners experienced significantly more muscle work than equivalent 
muscles in able-bodied runners, which emphasizes the importance of these muscles to 
running ability [35]. It is interesting to note that the single non-runner in the training 
group, while showing similar significant improvements in hip strength as the runners, 
started out with and ended with weaker hip muscles than the remainder of the group [27]. 
It is possible that given more time in the training program, this subject would have 
become strong enough to run. The non-runner also showed significant differences from 
the group in terms of kinematic behaviors (Table C.6 in Appendix C). This subject 
displayed shorter stride lengths for both limbs in the pre- and post-training assessments, 
as well as shorter prosthetic limb step length. The weakened hip flexors also manifested 
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in the sagittal plane hip movement; hip flexion on the prosthetic side was significantly 
less than the remainder of the runners.   
 
Even though there were no directly significant changes in the training group pre- and 
post- training trials, there were some interesting trends found in the control group. The 
TT control group took 3% shorter step lengths on the prosthetic side in the post trials as 
compared to the pre-testing assessment, as well as longer stance times and shorter swing 
times on their intact limb (Table 3.1), which is an undesirable trend which can cause 
loading asymmetries [18-20]. These trends also followed in the comparison of runners 
versus non-runners (Table 3.3). The results from the TF controls showed a trend towards 
a larger hip flexion on the intact side in the post-training trials, which indicated a 
stretching behavior in the intact limb.  It has been observed that in order to increase 
walking speed, lower-limb amputees take longer strides, rather than increasing step 
frequency [4]. Therefore, it seems likely that in order to maintain the walking speed of 1 
m/s, the TF subjects adopted a compensatory strategy in their intact leg. The fact that 
these metabolically and physiologically undesirable trends are occurring in the control 
group may indicate that while the training group did not necessarily show improvements 
in gait behavior, training prevented gait deterioration.  
 
Two key limitations of the current study may provide explanations for lack of observable 
changes in the training group kinematics. The current study focused on strengthening the 
hip flexors and extensors; however others have found that increased hip abductor strength 
correlates strongly with increased weight bearing on the prosthetic limb and improved 
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gait parameters, as well as decreased pelvic tilt and out-of-plane movement of the torso 
[2, 7, 10]. Future work should investigate if strengthening not only the hip flexors and 
extensors, but also the hip abductors, will allow kinematic differences to be observed. 
Another possible explanation for not finding statistical differences in the training group is 
the enforced 1m/s walking speed. Several studies have suggested that an increase in 
walking speed indicates an improvement in gait performance [14, 23-25], and it has long 
been acknowledged that changes in walking speed result in significant gait behavior 
changes in lower-limb amputees [2, 4, 8]. By having no data to validate the comfortable 
walking speed of each of the subjects, it was impossible to determine if the subjects were 
walking faster or slower than their desired pace, which would in turn affect gait behaviors. 
 
There were several other limitations to the study. One limitation was the inability to 
perform inverse dynamics on this data set. Although efforts were made to determine 
anthropometric characteristics of each prosthesis, there was a lack of information about 
the interface between the residual limb and prosthesis socket, which prevented further 
determination of the mass moments of inertia needed for inverse dynamics calculations. 
Future work should also examine the effect of the length of intervention. Perhaps given 
time, the one non-runner in the training group would develop sufficient strength to run. 
Another limitation was the variety of prosthesis types and levels of amputations, which 
resulted in small sample sizes when analyzing the data by amputation level and testing 
group. Both have been found to affect gait kinematics, and could explain why average 
group values showed no significant changes in the comparison between pre- and post- 
testing assessments.  
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We posit the following theory for why negligible changes in walking gait kinematics 
were observed in the training group post-intervention. The training program was targeted 
for improving physical performance with the ultimate goal of affording running ability. 
The initial analysis of this project found significant differences among the training group 
pre- and post-training in hip strength, metabolic energy expenditure and the ability to run. 
In the current study, however, we were unable to detect changes in walking gait 
biomechanics in this group. Walking ability is developed before running ability. Walking 
may be a less challenging or a simpler task to the neuromuscular system than running. 
Therefore, for this 10 week intervention that targeted running and not walking retraining, 
walking gait behavior may not have also been modified. Future work should also 
investigate existing literature as to whether this difference between observing no changes 
during simple tasks but documented changes during more complex tasks has been found 
in other populations.   
 
 
3.5. CONCLUSION 
 
This study was conducted to determine the plausibility of using a hip strength improving 
program to improve kinematic performance during walking and determine if the training 
was sufficient to enable running in lower-limb amputees. While there were no significant 
changes in kinematic behaviors for the training group in the pre- and post- training 
assessments, six of the seven training members were able to run after training. The 
control group, however, demonstrated several significant changes in gait behavior after 
ten weeks which indicated gait deterioration in this population, even though many of 
them continued their normal exercise regimes. This reemphasizes the need for constant 
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strength training to prevent muscle atrophy in the residual limb, as well as suggesting that 
strengthening the hip muscles may have prevented similar trends from occurring in the 
training group.   
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CHAPTER 4: CONCLUSIONS 
 
 
In an effort to improve motor function of lower-limb amputees, it was theorized that a hip 
strengthening training program would help to improve amputees’ kinematic performance. 
An additional aim of the study was to determine if the training program was sufficient to 
enable lower-limb amputees to run. Standard spatiotemporal characteristics, kinematic 
profiles, and gait event timings were all investigated in an attempt to understand the 
effect of the training on lower-limb amputees.  
 
The development of the piecewise linear length normalization technique (PLLN), 
utilizing clinically relevant gait events as points of interest, is described in Chapter 2. 
PLLN is a curve registration technique which linearly compresses or expands the time 
axis of a test curve to a target data set.  Gait events were used as the alignment points of 
interest on a knee-braced data set. By specifically selecting clinically-relevant gait events, 
it was possible to provide improved interpretation of gait behaviors, especially those 
behaviors that deviated from normative patterns. PLLN provided additional insights into 
gait behavior by giving more detailed information about the temporal shifts in gait 
patterns, as compared to other normalization techniques. These subtle timing shifts could 
potentially provide useful information about impaired control mechanisms of gait in other 
populations, such as stroke patients or lower-limb amputees. By aligning the data using 
PLLN, it was possible to examine changes in kinematic intensity behaviors at clinically 
relevant locations, and not just at peaks or valleys, as seen in other techniques.  
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Due to the advantages given by alignment of data with PLLN, it was chosen as a tool to 
analyze the amputee data set, along with standard spatiotemporal metrics and kinematic 
profile analysis. The results from this study showed that while there were no significant 
changes in kinematic gait behaviors for the training group in the pre- and post- training 
assessments, there were significant changes in the gait behaviors of the control group. 
The control group’s gait behaviors actually seemed to deteriorate over time, which re-
emphasized the need for constant strength training to prevent muscle atrophy in the 
residual limb. This deterioration also suggested that strengthening the hip muscles may 
have prevented similar trends from occurring in the training group. Hip strengthening 
also enabled six of the seven training group members to run, which was one of the aims 
of the study.  
 
The hip strengthening program showed some promising results. Specifically, the 
metabolic cost associated with walking decreased, the hip flexor/extensor strength of the 
training group increased, and all but one member of the training group were able to run. 
If the study were to be repeated, there are several changes to be made in the protocol. 
Since the hip abductors play a significant role in the kinematic behaviors of amputees, 
strengthening of these muscles in addition to the flexors should be considered. Walking 
trials should not be performed at one set walking speed, but should be tested at a set slow, 
set fast, and free individual comfortable walking speed. This could potentially eliminate 
the effects of walking speed on the kinematic results, as well as provide additional insight 
into the effect of the training on subject speed. An additional limitation of this study was 
the variety of prostheses and levels of amputation, which resulted in small sample sizes 
56  
when analyzing the data by amputation level and testing group. Both have been found to 
affect gait kinematics, and could explain why average group values showed no significant 
changes in the comparison between pre- and post- testing assessments.  
 
In general, while there were no significant improvements seen in the gait characteristics 
of the training group, the analysis demonstrated that the hip strengthening program 
prevented the gait deterioration seen in the control group, and did enable all but one 
member of the training group to run.  
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APPENDIX A: PLLN TIMINGS FOR HEALTHY ADULT MALES 
 
Table A.1: Individual Subject Average Timings for the Un-braced Data Set 
 
sim001 20 11 20 19 10 14 6
sim002 20 13 18 19 9 14 7
sim003 18 15 18 17 10 15 7
sim004 17 13 19 17 8 16 10
sim005 18 12 20 17 10 16 7
sim006 17 16 15 18 9 17 8
sim007 18 16 16 19 10 16 5
sim008 18 15 15 19 9 14 10
sim009 18 15 19 18 11 16 3
sim010 17 12 20 17 10 15 9
Average 18.1 13.8 18.0 18.0 9.6 15.3 7.2
stdev 1.1 1.8 2.0 0.9 0.8 1.1 2.2
sim001 19 11 21 20 9 9 11
sim002 19 14 16 20 9 9 13
sim003 17 15 19 18 10 9 12
sim004 17 10 20 17 9 10 17
sim005 17 14 18 18 9 11 13
sim006 18 14 17 17 9 8 17
sim007 19 15 18 18 10 9 11
sim008 20 14 17 18 9 7 15
sim009 18 15 19 18 11 10 9
sim010 17 12 20 17 10 10 14
Average 18.1 13.4 18.5 18.1 9.5 9.2 13.2
stdev 1.1 1.8 1.6 1.1 0.7 1.1 2.6
Left Leg (% GC)
Subject Loading Response
Mid-
Stance
Terminal 
Stance Pre-Swing
Initial 
Swing Mid-Swing
Terminal 
Swing
Initial 
Swing Mid-Swing
Terminal 
Swing
Right Leg (% GC)
Subject Loading Response
Mid-
Stance
Terminal 
Stance Pre-Swing
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Table A.2: Individual Subject Average Timings for the Braced Data Set 
 
sim001 16 8 21 16 11 17 11
sim002 15 10 17 6 21 15 16
sim003 15 15 18 17 11 16 8
sim004 15 13 19 17 9 17 10
sim005 15 10 22 16 11 16 10
sim006 15 14 17 17 10 17 10
sim007 13 10 23 16 12 16 10
sim008 13 10 22 16 13 16 10
sim009 14 14 20 18 12 15 7
sim010 14 8 23 16 15 16 8
Average 14.5 11.2 20.2 15.5 12.5 16.1 10.0
stdev 1.0 2.6 2.3 3.4 3.4 0.7 2.4
sim001 16 14 23 16 9 10 9
sim002 10 23 20 15 7 9 16
sim003 16 15 23 15 11 9 11
sim004 16 14 22 15 9 10 14
sim005 16 15 22 15 8 10 14
sim006 17 14 23 15 10 7 14
sim007 16 12 25 13 9 10 15
sim008 16 14 24 13 8 8 17
sim009 17 13 24 14 11 8 13
sim010 16 15 28 14 9 10 8
Average 15.6 14.9 23.4 14.5 9.1 9.1 13.1
stdev 2.0 3.0 2.1 1.0 1.3 1.1 2.9
Left Leg (% GC)
Subject Loading Response
Mid-
Stance
Terminal 
Stance Pre-Swing
Initial 
Swing Mid-Swing
Terminal 
Swing
Right Leg (% GC)
Subject Loading Response
Mid-
Stance
Terminal 
Stance Pre-Swing
Initial 
Swing Mid-Swing
Terminal 
Swing
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APPENDIX B: AMPUTEE SUBJECT CHARACTERISTICS 
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APPENDIX C: AMPUTEE SPATIOTEMPORAL CHARACTERISTICS 
Table C.1a: Individual spatiotemporal characteristics of Subject 1 
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Table C.1b: Individual spatiotemporal characteristics of Subject 2 
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Table C.1c: Individual spatiotemporal characteristics of Subject 3 
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Table C.1d Individual spatiotemporal characteristics of Subject 4 
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Table C.1j: Individual spatiotemporal characteristics of Subject 10 
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Table C.1k: Individual spatiotemporal characteristics of Subject 11 
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Table C.1l: Individual spatiotemporal characteristics of Subject 12 
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Table C.1m: Individual spatiotemporal characteristics of Subject 14 
 
St
rid
e 
Le
ng
th
TT
ES
T
St
rid
e 
Ti
m
e
TT
ES
T
St
ep
 L
en
gt
h
TT
ES
T
St
ep
 T
im
e
TT
ES
T
St
ep
 W
id
th
TT
ES
T
St
an
ce
 T
im
e 
(%
G
C
)
TT
ES
T
Sw
in
g 
Ti
m
e 
(%
G
C
)
TT
ES
T
0.
95
1.
10
0.
52
0.
60
0.
08
70
30
1.
07
1.
12
0.
45
0.
52
0.
14
68
32
1.
19
1.
17
0.
50
0.
57
0.
16
65
35
1.
18
1.
18
0.
55
0.
56
0.
14
65
35
1.
10
1.
09
0.
56
0.
56
0.
07
64
36
1.
13
1.
13
0.
49
0.
53
0.
11
65
35
1.
16
1.
09
0.
52
0.
55
0.
06
66
34
1.
18
1.
10
0.
54
0.
52
0.
16
65
35
1.
11
1.
22
0.
43
0.
56
0.
17
67
33
1.
11
1.
23
0.
45
0.
58
0.
13
66
34
Av
er
ag
e
1.
12
1.
14
0.
50
0.
55
0.
12
66
34
1.
06
1.
03
0.
51
0.
48
0.
17
68
32
1.
18
1.
09
0.
56
0.
51
0.
10
67
33
1.
27
1.
17
0.
56
0.
49
0.
16
65
35
1.
15
1.
14
0.
54
0.
54
0.
12
69
31
1.
15
1.
14
0.
55
0.
55
0.
11
65
35
1.
15
1.
06
0.
56
0.
50
0.
15
68
32
1.
20
1.
13
0.
53
0.
51
0.
12
67
33
1.
10
1.
17
0.
59
0.
55
0.
16
66
34
1.
03
1.
14
0.
55
0.
57
0.
06
71
29
1.
07
1.
17
0.
54
0.
54
0.
07
70
30
Av
er
ag
e
1.
14
1.
12
0.
55
0.
52
0.
12
68
32
1.
10
1.
20
0.
58
0.
61
0.
11
63
37
1.
14
1.
13
0.
62
0.
60
0.
11
61
39
1.
09
1.
09
0.
63
0.
61
0.
14
63
37
1.
09
1.
11
0.
60
0.
58
0.
15
63
37
1.
11
1.
12
0.
58
0.
57
0.
18
62
38
1.
14
1.
12
0.
62
0.
58
0.
15
62
38
1.
18
1.
07
0.
64
0.
55
0.
15
63
37
1.
06
1.
21
0.
63
0.
65
0.
06
63
37
1.
10
1.
18
0.
61
0.
61
0.
15
64
36
1.
08
1.
21
0.
67
0.
65
0.
14
64
36
Av
er
ag
e
1.
11
1.
14
0.
62
0.
60
0.
13
63
37
1.
06
1.
05
0.
55
0.
55
0.
13
60
40
1.
11
1.
09
0.
63
0.
58
0.
11
61
39
1.
27
1.
11
0.
71
0.
62
0.
18
58
42
1.
12
1.
13
0.
61
0.
60
0.
08
61
39
1.
14
1.
14
0.
60
0.
59
0.
12
62
38
1.
11
1.
08
0.
59
0.
55
0.
14
59
41
1.
13
1.
09
0.
60
0.
58
0.
13
61
39
1.
23
1.
15
0.
64
0.
60
0.
12
59
41
1.
11
1.
17
0.
56
0.
60
0.
15
62
38
1.
09
1.
15
0.
55
0.
60
0.
16
62
38
Av
er
ag
e
1.
14
1.
12
0.
60
0.
59
0.
13
60
40
SU
BJ
EC
T 
14
 (T
TC
)
0.
31
0.
04
0.
04
0.
95
0.
06
0.
01
0.
31
0.
46
0.
87
0.
28
0.
37
0.
14
0.
00
0.
00
In
ta
ct
 S
id
e 
Pr
e
In
ta
ct
 S
id
e 
Po
st
Pr
os
th
et
ic
 
Si
de
 P
re
Pr
os
th
et
ic
 
Si
de
 P
os
t
 73
Table C.1n: Individual spatiotemporal characteristics of Subject 15 
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Table C.1o: Individual spatiotemporal characteristics of Subject 16 
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Table C.2a: Control Groups’ spatiotemporal results arranged by type, session, and side 
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Table C.2b: Training Groups’ spatiotemporal results arranged by type, session, and side 
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Table C.4a: Spatiotemporal Results from the Non-runners, Pre- & Post- Testing. T-test btw 
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Table C.4b: Spatiotemporal Results from Runners, Pre- & Post- Testing. T-test btw 
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Table C.5a: Runners compared to Non-runners, pre-trials. T-test btw groups 
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Table C.5b: Runners compared to Non-runners, post-trials. T-test btw groups 
 
S
ub
je
ct
 1
1.
21
1.
20
0.
61
0.
55
0.
16
68
.6
31
.4
S
ub
je
ct
 2
1.
36
1.
37
0.
69
0.
65
0.
14
67
.4
32
.6
S
ub
je
ct
 3
1.
23
1.
25
0.
59
0.
63
0.
07
66
.0
34
.0
S
ub
je
ct
 4
1.
35
1.
30
0.
70
0.
57
0.
17
69
.1
30
.9
S
ub
je
ct
 5
1.
09
1.
17
0.
60
0.
51
0.
09
70
.8
29
.2
S
ub
je
ct
 9
1.
17
1.
20
0.
54
0.
49
0.
15
70
.3
29
.7
S
ub
je
ct
 1
0
1.
30
1.
38
0.
68
0.
66
0.
17
69
.5
30
.5
S
ub
je
ct
 1
4
1.
14
1.
12
0.
55
0.
52
0.
12
67
.6
32
.4
S
ub
je
ct
 1
6
1.
31
1.
27
0.
63
0.
63
0.
09
64
.4
35
.6
A
VE
R
A
G
E
1.
24
1.
25
0.
62
0.
58
0.
13
68
.2
31
.8
ST
D
EV
0.
09
0.
09
0.
0 6
0.
07
0.
04
2.
1
2.
1
S
ub
je
ct
 6
1.
19
1.
22
0.
58
0.
57
0.
17
69
.5
30
.5
S
ub
je
ct
 7
1.
27
1.
29
0.
63
0.
61
0.
06
67
.7
32
.3
S
ub
je
ct
 8
1.
25
1.
28
0.
52
0.
60
0.
19
67
.8
32
.2
S
ub
je
ct
 1
1
1.
20
1.
25
0.
60
0.
59
0.
09
67
.8
32
.2
S
ub
je
ct
 1
2
1.
44
1.
40
0.
72
0.
74
0.
11
63
.0
37
.0
S
ub
je
ct
 1
5
1.
31
1.
38
0.
64
0.
66
0.
14
69
.3
30
.7
A
VE
R
A
G
E
1.
28
1.
30
0.
61
0.
63
0.
13
67
.5
32
.5
ST
D
EV
0.
09
0.
07
0.
07
0.
06
0.
05
2.
4
2.
4
S
ub
je
ct
 1
1.
21
1.
20
0.
60
0.
65
0.
15
59
.7
40
.3
S
ub
je
ct
 2
1.
35
1.
37
0.
67
0.
72
0.
15
62
.8
37
.2
S
ub
je
ct
 3
1.
22
1.
25
0.
64
0.
62
0.
17
65
.2
34
.8
S
ub
je
ct
 4
1.
33
1.
31
0.
64
0.
73
0.
18
58
.0
42
.0
S
ub
je
ct
 5
1.
10
1.
17
0.
51
0.
66
0.
06
59
.2
40
.8
S
ub
je
ct
 9
1.
19
1.
20
0.
65
0.
72
0.
18
61
.5
38
.5
S
ub
je
ct
 1
0
1.
30
1.
38
0.
63
0.
73
0.
17
64
.1
35
.9
S
ub
je
ct
 1
4
1.
14
1.
12
0.
60
0.
59
0.
13
60
.3
39
.7
S
ub
je
ct
 1
6
1.
27
1.
24
0.
67
0.
64
0.
07
63
.8
36
.2
A
VE
R
A
G
E
1.
23
1.
25
0.
62
0.
67
0.
14
61
.6
38
.4
ST
D
EV
0.
09
0.
09
0.
0 5
0.
05
0.
05
2.
5
2.
5
S
ub
je
ct
 6
1.
18
1.
22
0.
60
0.
65
0.
16
66
.6
33
.4
S
ub
je
ct
 7
1.
29
1.
28
0.
66
0.
69
0.
09
61
.1
38
.9
S
ub
je
ct
 8
1.
23
1.
25
0.
74
0.
68
0.
18
64
.7
35
.3
S
ub
je
ct
 1
1
1.
19
1.
26
0.
59
0.
67
0.
07
62
.5
37
.5
S
ub
je
ct
 1
2
1.
46
1.
38
0.
76
0.
67
0.
12
64
.2
35
.8
S
ub
je
ct
 1
5
1.
32
1.
35
0.
69
0.
70
0.
12
66
.2
33
.8
A
VE
R
A
G
E
1.
28
1.
29
0.
67
0.
68
0.
12
64
.2
35
.8
ST
D
EV
0.
10
0.
06
0.
0 7
0.
02
0.
04
2.
1
2.
1
A
vg
 S
ta
nc
eT
im
e 
(%
G
C
)
T-
TE
ST
A
vg
 
Sw
in
gT
im
e 
T-
TE
S
T
Av
g 
S
te
p 
W
id
th
 (m
)
T-
TE
S
T
A
vg
 S
tr
id
e 
Le
ng
th
 (m
)
T-
TE
ST
A
vg
 S
tr
id
e 
Ti
m
e 
(s
)
T-
TE
S
T
A
vg
 S
te
p 
Le
ng
th
 (m
)
T-
TE
S
T
A
vg
 S
te
p 
Ti
m
e 
(s
)
0.
03
0.
03
0.
19
0.
17
0.
06
0.
42
0.
27
0.
42
0.
10
0.
50
0.
29
0.
29
T-
TE
ST
N
R
P
os
t
I
R
P
os
t
PI
N
R
P
os
t
P
0.
24
0.
12
R
P
os
t
 83
Table C.6: Spatiotemporal results from the single non-runner in the control group as 
compared to the remainder of the runners, both pre- and post- testing. 
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APPENDIX D: KINEMATIC PROFILES 
 
Table D.1a: Control groups’ individual hip flexion ROM, paired t-tests by session, 
within side 
 
Pre Post T-TEST Pre Post T-TEST Pre Post T-TEST Pre Post T-TEST
40.3 54.8 47.0 52.7 41.9 48.8 48.5 43.5
42.0 54.6 50.1 48.1 38.9 47.8 45.0 42.6
37.4 53.9 44.8 45.5 40.0 44.6 47.9 44.0
45.1 48.3 52.8 49.2 42.4 49.8 45.8 42.1
45.3 50.5 53.5 48.2 39.8 47.9 50.2 41.6
51.8 46.5 56.4 43.9 41.6 48.0 44.9 40.8
50.8 48.4 47.9 47.5 40.5 45.5 43.5 44.6
48.4 43.5 49.3 55.6 40.1 49.6 46.3 45.3
42.9 41.0 43.5 51.4 40.4 49.4 44.1 39.7
40.1 47.2 48.4 55.8 39.7 50.2 41.8 45.3
34.3 35.7 37.4 31.4 50.5 47.5 42.0 47.7
37.2 37.0 31.5 32.1 49.5 47.4 43.2 49.4
40.2 37.9 31.5 38.9 48.9 46.1 43.1 48.6
37.2 37.8 34.6 39.3 47.7 47.0 45.1 48.4
40.1 35.2 30.4 31.8 47.4 45.2 42.5 49.2
37.7 35.9 34.3 35.6 48.7 50.2 43.0 50.1
39.2 36.6 33.6 31.7 45.3 50.2 43.6 50.1
40.0 38.4 32.7 35.7 47.7 45.9 41.2 47.6
37.5 34.6 30.7 32.0 50.3 46.8 43.2 45.3
35.2 37.6 31.9 31.3 46.8 44.4 42.3 47.8
40.9 41.5 38.8 43.5 31.3 39.9 46.0 42.5
41.8 39.2 39.9 45.6 29.5 42.9 48.4 40.2
42.6 38.7 44.8 42.8 31.0 42.2 44.0 46.9
41.5 39.7 39.4 44.0 30.5 39.0 46.1 43.5
40.9 39.2 38.1 45.0 31.5 40.8 44.9 44.3
40.8 42.5 39.0 41.9 30.3 45.7 48.2 44.8
41.8 43.0 41.0 43.2 33.0 38.7 45.0 42.1
42.0 41.9 37.4 41.1 30.8 38.7 42.4 48.1
41.9 39.0 39.6 41.5 31.8 49.0 43.6 46.4
40.3 41.1 41.9 41.0 30.9 38.5 46.7 43.7
39.1 49.1 34.7 33.9
35.9 48.0 37.1 36.7
35.0 52.0 34.9 33.3
31.8 48.3 36.0 34.8
34.5 56.2 43.7 37.6
35.9 54.5 39.5 37.6
37.9 54.1 43.5 37.7
39.3 54.7 44.3 34.2
37.8 55.1 43.2 37.5
29.8 51.8 38.1 33.6
45.6 51.2 42.4 32.9
49.3 56.3 42.1 51.0
43.0 52.9 41.4 39.3
43.3 53.3 42.1 38.1
36.7 53.3 50.2 33.0
46.4 53.1 39.2 34.5
33.2 56.0 50.5 34.2
39.0 58.0 39.9 35.2
38.7 53.0 42.1 34.5
42.7 54.7 41.6 39.4
0.017
0.013
Transtibial Controls
Prosthetic Side
Transfemoral Controls
Prosthetic Side
Subject
Intact Side
Subject
s010 0.000
0.002s009 0.000
0.000 0.171s016 0.097 s0040.004
0.082 0.000s014 0.062 s0020.174
0.000s003 0.058 s0010.422
Intact Side
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Table D.1b: Training groups’ individual hip flexion ROM, paired t-tests by session, 
within side 
 
Pre Post T-TEST Pre Post T-TEST Pre Post T-TEST Pre Post T-TEST
38.1 39.2 31.0 30.6 37.1 51.5 42.139 37.809
46.3 42.9 29.0 37.6 35.2 54.2 42.455 41.030
41.4 43.7 28.0 29.9 29.6 48.0 32.466 36.394
44.8 40.5 26.9 33.5 39.8 47.6 36.270 37.939
41.7 42.7 26.0 31.5 36.4 47.5 35.350 36.729
44.5 41.8 23.7 34.9 42.5 47.1 35.225 36.528
40.9 42.4 29.5 34.0 40.1 61.0 36.838 37.418
36.0 47.5 29.9 35.4 37.9 48.4 36.547 38.430
35.4 44.6 27.7 31.9 37.6 46.3 36.694 38.060
46.0 43.7 25.1 32.9 38.9 46.4 34.983 43.281
39.1 40.4 39.7 42.1 31.3 47.5 40.177 32.897
44.8 40.0 40.2 42.2 62.6 48.9 38.462 38.668
42.7 40.7 40.1 41.2 48.4 48.0 37.364 35.158
42.3 40.6 34.5 41.4 45.3 49.4 28.584 29.752
38.2 42.9 36.5 40.2 45.2 46.7 34.853 33.414
43.0 43.5 40.4 42.2 42.9 43.7 33.041 30.179
40.4 38.0 42.3 41.4 37.1 45.6 30.165 31.586
42.7 45.1 38.2 41.2 43.2 45.7 25.737 29.926
38.0 44.7 39.1 43.4 45.6 46.9 28.701 32.655
40.5 40.9 43.7 42.3 45.4 44.6 28.786 29.684
45.1 40.3 45.8 46.9 55.8 53.9 46.461 52.994
47.3 45.6 44.0 48.4 55.8 51.0 46.461 53.103
44.0 42.2 48.6 44.1 54.4 52.4 43.957 51.689
45.1 42.3 53.1 49.8 51.4 56.1 44.281 48.172
42.9 44.4 47.7 53.1 54.8 60.1 41.116 51.536
43.5 47.2 45.1 44.8 51.8 55.4 43.446 47.587
41.6 47.7 46.7 46.1 50.7 55.7 42.503 43.103
45.8 42.1 45.9 48.0 53.3 54.9 40.593 50.864
43.0 48.7 45.9 59.8 49.8 - 42.295 46.667
45.2 44.2 51.4 48.1 57.5 - 38.987 54.872
37.7 53.3 49.1 55.4
38.9 47.7 50.9 53.9
38.5 51.9 50.0 46.9
39.2 58.5 48.6 48.6
35.8 51.2 47.5 45.1
43.5 54.4 50.8 49.1
38.6 51.6 51.0 47.1
40.1 52.3 48.7 53.3
37.7 48.0 50.2 50.0
39.5 46.7 47.7 47.5
Transfemoral Training
Subject
Intact Side Prosthetic Side
0.095
0.829
0.430
0.000
Transtibial Training
Subject
Intact Side
0.000s012
s015 0.1640.409s011 0.460
s008 0.2110.015s006 0.326
s007 0.0000.000s005 0.210
Prosthetic Side
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Table D.2: Averaged hip flexion ROM paired t-tests within group, type and side by 
session 
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Table D.3: Individual hip flexion ROM paired t-tests within running ability, type and side by 
session 
Subject min max difference min max difference T Test
s001 -10.7 29.7 40.4 -14.8 32.4 47.2
s002 -20.1 27.8 47.9 -17.5 28.9 46.4
s003 -12.6 30.5 43.1 -21.3 26.9 48.3
s004 -2.6 28.0 30.6 -8.4 31.8 40.2
s005 -5.2 35.1 40.4 -1.8 39.9 41.7
s009 -2.1 31.9 34.0 -14.9 36.3 51.2
s010 -9.5 31.0 40.5 -20.4 31.3 51.7
s014 -18.7 18.2 36.8 -10.0 25.2 35.1
s016 -15.5 24.8 40.3 -11.2 27.5 38.7
s006 -18.1 21.9 40.0 -17.5 23.1 40.6
s007 -12.2 24.1 36.3 -19.9 28.3 48.1
s008 -8.0 35.4 43.4 -19.7 26.1 45.8
s011 -20.6 22.8 43.4 -13.5 28.7 42.2
s012 -5.4 33.0 38.4 -21.4 28.1 49.4
s015 -21.4 30.6 52.1 -19.2 33.0 52.3
Intact Side
Pre Post
Non-
Runners 0.02
Runners 0.07
T-TEST NR to R 0.16 0.24
 
Subject min max difference min max difference T Test
s001 -15.2 30.2 45.4 -14.8 27.8 42.6
s002 -23.6 18.7 42.3 -26.8 21.1 47.8
s003 -12.2 35.9 48.2 -20.0 28.2 48.2
s004 -10.9 34.0 45.0 -15.0 28.7 43.8
s005 -0.8 26.3 27.2 1.7 34.2 32.5
s009 -7.0 30.9 37.9 -6.1 29.1 35.2
s010 -12.4 29.4 41.8 -10.9 23.6 34.5
s014 -10.8 21.2 32.0 -7.1 25.6 32.7
s016 -12.5 26.9 39.4 -9.6 32.3 41.9
s006 -8.2 30.5 38.8 -10.4 30.7 41.1
s007 -17.9 18.1 36.0 -20.8 17.1 37.8
s008 -5.0 24.9 29.8 -9.4 22.0 31.4
s011 -22.1 25.0 47.1 -15.7 30.1 45.9
s012 -9.2 39.2 48.4 -11.5 36.8 48.3
s015 -19.4 23.2 42.6 -18.1 30.9 49.0
Prosthetic Side
Pre Post
0.50
0.08
Non-
Runners
Runners
0.26T-TEST NR to R 0.44
 
 
Table D.4: Training group non-runner vs. remaining runners hip flexion ROM 
Average SD -1 SD +1 SD -2 SD +2 SD Subject 5
Pre 42.3 5.6 36.7 47.8 31.1 53.4 40.4
Post 46.4 4.4 42.0 50.8 37.6 55.3 41.7
Pre 40.5 7.0 33.4 47.5 26.4 54.5 27.2
Post 42.3 6.8 35.4 49.1 28.6 55.9 32.5
I
P
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Table D.5a: Control groups’ individual pelvic COM ROM, paired t-test by session  
Subject Pre Post T-TEST Subject Pre Post T-TEST
0.039 0.051 0.051 0.061
0.046 0.050 0.050 0.055
0.042 0.043 0.043 0.060
0.052 0.048 0.041 0.058
0.048 0.038 0.048 0.056
0.066 0.038 0.044 0.055
0.047 0.046 0.037 0.055
0.048 0.041 0.042 0.063
0.036 0.039 0.040 0.057
0.043 0.050 0.037 0.059
0.045 0.034 0.062 0.067
0.055 0.041 0.081 0.072
0.047 0.049 0.076 0.074
0.047 0.045 0.078 0.079
0.044 0.042 0.067 0.069
0.051 0.039 0.079 0.066
0.047 0.038 0.068 0.066
0.043 0.046 0.070 0.065
0.045 0.043 0.067 0.067
0.049 0.045 0.068 0.068
0.058 0.049 0.062 0.052
0.054 0.047 0.051 0.051
0.054 0.044 0.057 0.060
0.048 0.038 0.058 0.056
0.052 0.041 0.049 0.053
0.053 0.044 0.056 0.062
0.050 0.043 0.055 0.058
0.054 0.037 0.060 0.062
0.051 0.046 0.065 0.064
0.056 0.051 0.056 0.054
0.068 0.057
0.056 0.064
0.042 0.076
0.049 0.064
0.062 0.074
0.061 0.071
0.060 0.074
0.068 0.077
0.052 0.069
0.061 0.072
0.057 0.057
0.070 0.060
0.064 0.051
0.054 0.054
0.055 0.056
0.049 0.051
0.054 0.053
0.048 0.058
0.047 0.056
0.057 0.053
s001
s002
s004
0.004
0.344
Transtibial Controls Transfemoral Controls
0.000
0.000
0.084
0.376
s010
s003
s009
s014
s016
0.276
0.010
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Table D.5b: Training groups’ individual pelvic COM ROM, paired t-test by session  
 
Subject Pre Post T-TEST Subject Pre Post T-TEST
0.051 0.048 0.056 0.065
0.041 0.051 0.045 0.064
0.052 0.045 0.054 0.056
0.048 0.048 0.055 0.048
0.046 0.045 0.063 0.056
0.043 0.055 0.057 0.051
0.051 0.053 0.051 0.065
0.040 0.056 0.056 0.061
0.055 0.051 0.048 0.054
0.044 0.053 0.052 0.057
0.040 0.044 0.054 0.057
0.051 0.049 0.054 0.069
0.050 0.043 0.056 0.060
0.045 0.044 0.048 0.057
0.050 0.042 0.059 0.055
0.052 0.051 0.062 0.042
0.055 0.048 0.057 0.054
0.052 0.050 0.053 0.052
0.051 0.053 0.056 0.058
0.058 0.046 0.051 0.056
0.035 0.038 0.049 0.053
0.044 0.050 0.049 0.058
0.045 0.043 0.050 0.047
0.043 0.045 0.046 0.058
0.040 0.044 0.049 0.056
0.036 0.052 0.044 0.056
0.041 0.043 0.052 0.051
0.047 0.041 0.045 0.066
0.048 0.042 0.043 0.067
0.044 0.043 0.048 0.062
0.053 0.061
0.051 0.051
0.043 0.055
0.044 0.051
0.058 0.061
0.064 0.056
0.071 0.073
0.045 0.052
0.050 0.058
0.047 0.057
s015 0.002
Transfemoral Training
s007 0.105
s008 0.371
s011 0.190
s012 0.012
Transtibial Training
s005 0.113
s006 0.041
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Table D.6: Pelvic COM ROM paired t-test within running ability and by session 
Subject min max difference min max difference T Test
s001 0.870 0.913 0.043 0.839 0.896 0.057
s002 0.889 0.960 0.071 0.877 0.946 0.069
s003 0.836 0.880 0.044 0.817 0.859 0.042
s004 0.998 1.054 0.056 0.944 0.997 0.054
s005 1.030 1.076 0.046 0.978 1.025 0.048
s009 0.942 0.998 0.056 0.868 0.936 0.068
s010 1.036 1.088 0.053 0.994 1.047 0.053
s014 0.922 0.967 0.045 0.910 0.949 0.039
s016 0.892 0.943 0.051 0.889 0.931 0.043
s006 0.840 0.888 0.049 0.888 0.933 0.046
s007 0.963 1.013 0.050 0.912 0.967 0.054
s008 1.007 1.061 0.054 0.933 0.988 0.056
s011 1.036 1.088 0.053 0.823 0.864 0.042
s012 0.960 1.007 0.047 0.932 0.986 0.054
s015 0.931 0.977 0.045 0.886 0.940 0.054
T-TEST NR to R 0.561 0.724
Non-Runners 0.767
0.715
PELVIS ROM (M) SUMMARY
Pre Post
Runners
 
 
Table D.7: Training group non-runner pelvic COM ROM as compared to runners 
Average SD -1 SD +1 SD -2 SD +2 SD Subject 5
Pre 0.050 0.003 0.047 0.053 0.044 0.056 0.046
Post 0.051 0.006 0.045 0.057 0.039 0.063 0.048  
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APPENDIX E: PIECEWISE LINEAR LENGTH NORMALIZATION DETAILS 
Table E.1a: Control Group PLLN gait event timings, paired t-test within type and side, 
by session 
Control Group
Subject 3 13 17 19 16 35
Subject 14 14 16 22 14 34
Subject 16 14 19 18 13 36
AVERAGE 13.7 17.3 19.7 14.3 35.0
STDEV 0.6 1.5 2.1 1.5 1.0
Subject 3 14 16 19 17 34
Subject 14 13 20 20 15 32
Subject 16 15 22 14 14 35
AVERAGE 14.00 19.33 17.67 15.33 33.67
STDEV 1.00 3.06 3.21 1.53 1.53
Subject 3 16 19 17 13 35
Subject 14 14 18 16 15 37
Subject 16 14 19 17 14 36
AVERAGE 14.7 18.7 16.7 14.0 36.0
STDEV 1.2 0.6 0.6 1.0 1.0
Subject 3 17 17 17 14 35
Subject 14 15 17 15 13 40
Subject 16 14 23 13 14 36
AVERAGE 15.33 19.00 15.00 13.67 37.00
STDEV 1.53 3.46 2.00 0.58 2.65
Subject 1 14 23 17 15 31
Subject 2 17 20 17 15 31
Subject 4 16 23 16 15 30
Subject 9 22 8 30 11 30
Subject 10 16 19 17 17 31
AVERAGE 17.0 18.6 19.4 14.6 30.6
STDEV 3.0 6.2 5.9 2.2 0.5
Subject 1 14 18 22 14 32
Subject 2 15 20 18 15 32
Subject 4 13 23 20 13 31
Subject 9 21 14 25 10 30
Subject 10 17 20 16 17 30
AVERAGE 16.0 19.0 20.2 13.8 31.0
STDEV 3.2 3.3 3.5 2.6 1.0
Subject 1 15 16 15 14 40
Subject 2 15 16 15 17 37
Subject 4 16 22 7 16 39
Subject 9 10 22 8 22 38
Subject 10 16 13 20 16 35
AVERAGE 14.4 17.8 13.0 17.0 37.8
STDEV 2.5 4.0 5.4 3.0 1.9
Subject 1 14 13 19 14 40
Subject 2 15 18 15 15 37
Subject 4 13 19 12 14 42
Subject 9 10 23 7 21 39
Subject 10 17 13 17 17 36
AVERAGE 13.8 17.2 14.0 16.2 38.8
STDEV 2.6 4.3 4.7 2.9 2.4
Pre-Swing T-Test Swing T-Test
T-TestTranstibial
Transfemoral
Loading 
Response T-Test Mid-Stance T-Test
Terminal 
Stance T-Test
T-Test Pre-Swing T-Test SwingLoading Response Mid-Stance
Terminal 
StanceT-Test T-Test
Pre P
Post P
Pre I
Post I
Pre P
Post P
Pre I
Post I
0.33
0.09
0.12
0.21
0.16
0.44
0.42
0.30
0.11
0.15
0.34
0.27
0.23
0.37
0.05
0.12
0.03
0.21
0.19
0.07
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Table E.1b: Training Group PLLN gait event timings, paired t-test within type and side, 
by session 
 
Training Group
Subject 5 17 23 18 15 27
Subject 6 18 14 20 19 29
Subject 11 17 17 20 12 34
Subject 12 11 19 19 15 36
AVERAGE 15.8 18.3 19.3 15.3 31.5
STDEV 3.2 3.8 1.0 2.9 4.2
Subject 5 16 22 19 14 29
Subject 6 20 14 20 16 30
Subject 11 15 15 23 15 32
Subject 12 11 20 17 15 37
AVERAGE 15.5 17.8 19.8 15.0 32.0
STDEV 3.7 3.9 2.5 0.8 3.6
Subject 5 15 16 13 17 39
Subject 6 18 18 12 19 33
Subject 11 14 14 17 16 39
Subject 12 13 19 19 11 38
AVERAGE 15.0 16.8 15.3 15.8 37.3
STDEV 2.2 2.2 3.3 3.4 2.9
Subject 5 14 15 14 16 41
Subject 6 17 18 12 20 33
Subject 11 15 14 18 15 38
Subject 12 15 22 16 11 36
AVERAGE 15.3 17.3 15.0 15.5 37.0
STDEV 1.3 3.6 2.6 3.7 3.4
Subject 7 13 19 19 15 34
Subject 8 18 17 19 14 32
Subject 15 17 20 14 17 32
AVERAGE 16.0 18.7 17.3 15.3 32.7
STDEV 2.6 1.5 2.9 1.5 1.2
Subject 7 15 18 20 15 32
Subject 8 17 16 20 15 32
Subject 15 17 19 15 18 31
AVERAGE 16.3 17.7 18.3 16.0 31.7
STDEV 1.2 1.5 2.9 1.7 0.6
Subject 7 16 20 15 13 36
Subject 8 14 27 5 19 35
Subject 15 18 19 14 17 33
AVERAGE 16.0 22.0 11.3 16.3 34.7
STDEV 2.0 4.4 5.5 3.1 1.5
Subject 7 15 17 15 14 39
Subject 8 15 26 7 17 35
Subject 15 17 17 14 18 34
AVERAGE 15.7 20.0 12.0 16.3 36.0
STDEV 1.2 5.2 4.4 2.1 2.6
Swing T-TestTransfemoral
Swing T-Test
Loading 
Response T-Test Mid-Stance T-Test
Terminal 
Stance T-Test Pre-Swing T-Test
Terminal 
Stance T-Test Pre-Swing T-Test
Loading 
Response T-Test Mid-Stance T-TestTranstibial
Pre P
Post P
Pre I
Post I
Pre P
Post P
Pre I
Post I
0.39
0.38
0.37
0.33
0.25
0.30
0.23
0.04
0.33
0.40
0.35
0.21
0.43
0.32
0.32
0.50
0.43
0.39
0.13
0.13
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Table E.2a: Non-Runner PLLN gait event timings, paired t-test within side, by session 
Non-Runners
Subject 1 14 23 17 15 31
Subject 2 17 20 17 15 31
Subject 3 13 17 19 16 35
Subject 4 16 23 16 15 30
Subject 5 17 23 18 15 27
Subject 9 22 8 30 11 30
Subject 10 16 19 17 17 31
Subject 14 14 16 22 14 34
Subject 16 14 19 18 13 36
AVERAGE 15.9 18.7 19.3 14.6 31.7
STDEV 2.7 4.8 4.4 1.7 2.8
Subject 1 14 18 22 14 32
Subject 2 15 20 18 15 32
Subject 3 14 16 19 17 34
Subject 4 13 23 20 13 31
Subject 5 16 22 19 14 29
Subject 9 21 14 25 10 30
Subject 10 17 20 16 17 30
Subject 14 13 20 20 15 32
Subject 16 15 22 14 14 35
AVERAGE 15.3 19.4 19.2 14.3 31.7
STDEV 2.5 3.0 3.2 2.1 1.9
Subject 1 15 16 15 14 40
Subject 2 15 16 15 17 37
Subject 3 16 19 17 13 35
Subject 4 16 22 7 16 39
Subject 5
Subject 9 10 22 8 22 38
Subject 10 16 13 20 16 35
Subject 14 14 18 16 15 37
Subject 16 14 19 17 14 36
AVERAGE 14.5 18.1 14.4 15.9 37.1
STDEV 2.0 3.1 4.5 2.8 1.8
Subject 1 14 13 19 14 40
Subject 2 15 18 15 15 37
Subject 3 17 17 17 14 35
Subject 4 13 19 12 14 42
Subject 5 14 15 14 16 41
Subject 9 10 23 7 21 39
Subject 10 17 13 17 17 36
Subject 14 15 17 15 13 40
Subject 16 14 23 13 14 36
AVERAGE 14.3 17.6 14.3 15.3 38.4
STDEV 2.1 3.7 3.5 2.4 2.5
Pre Trials Intact Limb
Post Trials Intact Limb
Pre Trials Prosthetic Limb
Post Trials Prosthetic Limb
T-TestLoading Response
Mid-
StanceT-Test T-Test Swing T-Test
0.28 0.49 0.92 0.56 1.00
Terminal 
Stance T-Test Pre-Swing
0.070.80 0.78 1.00 0.22  
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Table E.2b: Runner PLLN gait event timings, paired t-test within side, by session 
Subject 6 18 14 20 19 29
Subject 7 13 19 19 15 34
Subject 8 18 17 19 14 32
Subject 11 17 17 20 12 34
Subject 12 11 19 19 15 36
Subject 15 17 20 14 17 32
AVERAGE 15.7 17.7 18.5 15.3 32.8
STDEV 2.9 2.2 2.3 2.4 2.4
Subject 6 20 14 20 16 30
Subject 7 15 18 20 15 32
Subject 8 17 16 20 15 32
Subject 11 15 15 23 15 32
Subject 12 11 20 17 15 37
Subject 15 17 19 15 18 31
AVERAGE 15.8 17.0 19.2 15.7 32.3
STDEV 3.0 2.4 2.8 1.2 2.4
Subject 6 18 18 12 19 33
Subject 7 16 20 15 13 36
Subject 8 14 27 5 19 35
Subject 11 14 14 17 16 39
Subject 12 13 19 19 11 38
Subject 15 18 19 14 17 33
AVERAGE 15.5 19.5 13.7 15.8 35.7
STDEV 2.2 4.2 4.9 3.3 2.5
Subject 6 17 18 12 20 33
Subject 7 15 17 15 14 39
Subject 8 15 26 7 17 35
Subject 11 15 14 18 15 38
Subject 12 15 22 16 11 36
Subject 15 17 17 14 18 34
AVERAGE 15.7 19.0 13.7 15.8 35.8
STDEV 1.0 4.3 3.8 3.2 2.3
T-Test Swing T-Test
Runners
T-Test Terminal Stance T-Test Pre-Swing
Loading 
Response T-Test
Mid-
Stance
0.820.77 0.58 1.00 1.00
0.81 0.17 0.36 0.70 0.41
Pre Trials Prosthetic Limb
Post Trials Prosthetic Limb
Pre Trials Intact Limb
Post Trials Intact Limb
 
 
Table E.3: PLLN gait event timings for single training group non-runners as compared 
to runners 
 
Average SD -1 SD +1 SD -2 SD +2 SD -3 SD +3 SD Subject 5
Pre 15.7 2.9 12.8 18.6 9.9 21.5 7.0 24.4 17
Post 15.8 3.0 12.8 18.8 9.8 21.8 6.8 24.8 16
Pre 15.5 2.2 13.3 17.7 11.1 19.9 8.9 22.1 15
Post 15.7 1.0 14.7 16.7 13.7 17.7 12.7 18.7 14
Pre 17.7 2.2 15.5 19.9 13.3 22.1 11.1 24.3 23
Post 17.0 2.4 14.6 19.4 12.2 21.8 9.8 24.2 22
Pre 19.5 4.2 15.3 23.7 11.1 27.9 6.9 32.1 16
Post 19.0 4.3 14.7 23.3 10.4 27.6 6.1 31.9 15
Pre 18.5 2.3 16.2 20.8 13.9 23.1 11.6 25.4 18
Post 19.2 2.8 16.4 22.0 13.6 24.8 10.8 27.6 19
Pre 13.7 4.9 8.8 18.6 3.9 23.5 -1.0 28.4 13
Post 13.7 3.8 9.9 17.5 6.1 21.3 2.3 25.1 14
Pre 15.3 2.4 12.9 17.7 10.5 20.1 8.1 22.5 15
Post 15.7 1.2 14.5 16.9 13.3 18.1 12.1 19.3 14
Pre 15.8 3.3 12.5 19.1 9.2 22.4 5.9 25.7 17
Post 15.8 3.2 12.6 19.0 9.4 22.2 6.2 25.4 16
Pre 32.8 2.4 30.4 34.7 28.0 37.1 25.6 39.5 27
Post 32.3 2.4 29.9 34.7 27.5 37.1 25.1 39.5 29
Pre 35.7 2.5 33.2 38.2 30.7 40.7 28.2 43.2 39
Post 35.8 2.3 33.5 38.1 31.2 40.4 28.9 42.7 41
P
Swing
I
P
Pre-Swing
I
I
P
I
Mid-Stance
Terminal 
Stance
P
Loading 
Response
P
I
 
 
